Yayınlar & Eserler

ATLAS Yayın Analitiği
Makaleler 223
Tümü (223)
SCI-E, SSCI, AHCI (186)
SCI-E, SSCI, AHCI, ESCI (194)
ESCI (1)
Scopus (198)
TRDizin (36)
Diğer Yayınlar (3)

1. Prospective Follow-up of Panel Reactive Antibodies From Diagnosis Until Completion of Therapy Including Allogeneic Stem Cell Transplantation Among Patients With Acute Leukemia.

Sahin Eroglu D., Dalva K., Kalaci E., Toprak S. K., Civriz Bozdag S., Topcuoglu P., et al.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation , cilt.24, ss.165-172, 2026 (SCI-Expanded, Scopus)

2. TP53 MUTATION AND MSS-WM IDENTIFY HIGH RISK WALDENSTROM MACROGLOBULINEMIA IN A REAL WORLD COHORT

Calis U., YÜKSEL S., YÜKSEL M., TOPÇUOĞLU P., KUZU I., ARSLAN Ö., et al.
Haematologica , cilt.111, sa.2, ss.1, 2026 (SCI-Expanded, Scopus)

3. Allogeneic Hematopoietic Cell Transplantation for Relapsed / Refractory Hodgkin Lymphoma: A Multicenter Real-World Experience.

Koyun D., Şahin U., Cengiz Seval G., Gören D., Gökmen A., Civriz Bozdağ S., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.43, ss.116-130, 2026 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

4. Higher Pretransplant Lymphocyte Count Is Associated With Improved Survival in Allogeneic Stem Cell Transplantation With Antithymocyte Globulin

Kokcu G., DALVA K., Yuksel M. K., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.25, 2025 (SCI-Expanded, Scopus)

5. CT-1425: Higher Pretransplant Lymphocyte Count Is Associated With Improved Survival in Allogeneic Stem Cell Transplantation With Antithymocyte Globulin

Kökcü G., Dalva K., Yüksel M., Toprak S. K., Topçuoğlu P., Arslan Ö., et al.
Clinical Lymphoma Myeloma and Leukemia , cilt.25, ss.1065, 2025 (Hakemli Dergi) Creative Commons License

6. Akut Miyeloid Lösemi Tanılı Fit Yaşlı Hastalarda Allojeneik Hematopoetik Kök Hücre Nakli: Tek Merkez Deneyimi

SÖNMEZ G. M., YAVUZ G., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.9, 2025 (TRDizin)

7. Periferik T-Hücreli Lenfoma Hastalarının Geriye Dönük Değerlendirmesi: Tek Merkez Gerçek Yaşam Deneyimi

YÜKSEL M., . C. K. D., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.9, 2025 (TRDizin)

8. Hodgkin Lenfomalı Hastalarda Tedavi Sonrası Geç Dönemde Yüksek Hematokrit Değerleri: Lenfoma ile Eritrositoz Arasında İlişki mi var?

KOYUN D., ATEŞAĞAOĞLU B., YÜKSEL S., SEVAL G. C., BOZDAĞ S. C., TOPRAK S. K., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.8, sa.3, ss.86-91, 2024 (TRDizin) Creative Commons License

9. Anaplastic Multiple Myeloma: An Aggressive Myeloma Variant with A Poor Response to Autologous Stem Cell Transplantation

Koyun D., Doğan İ. Ö., Kuzu I., Toprak S. K., Özcan M., Demirer T.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.77, sa.4, ss.416-418, 2024 (TRDizin)

10. Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center

CENGİZ SEVAL G., Civriz Bozdag S., TOPRAK S. K., Kurt Yuksel M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Balkan medical journal , cilt.40, sa.3, ss.197-204, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

11. Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data

Kırcalı E., Cengiz Seval G., Öztürk C., Yılmaz H., Koyun D., Civriz Bozdağ S., et al.
BALKAN MEDICAL JOURNAL , cilt.40, sa.1, ss.51-56, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

12. Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia

Ozdemir Z. N., Kircali E., Şahin U., Seval G., Bozdağ S. C., Toprak S. K., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.22, sa.8, ss.596-600, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Alpha-1-Antitrypsin Experience for Steroid-Resistant Acute Graft-Versus-Host Disease

KOYUN D., CENGİZ SEVAL G., Kircali E., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , cilt.38, sa.3, ss.601-605, 2022 (SCI-Expanded, Scopus)

14. İkinci Allojenik Kök Hücre Nakli: Gerçek Yaşam Verisi

KIRCALI E., CENGİZ SEVAL G., ÖZTÜRK C., YILMAZ H., ŞENOYMAK M. C., YAVUZ G., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.6, sa.2, ss.50-55, 2022 (TRDizin)

15. The efficacy and safety of second allogeneic hematopoietic stem cell transplantation.

Toprak S. K., Korcalo E., Seval G. C., Bozdag S. C., Yuksel M. K., Topcuoglu P., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.40, sa.16, 2022 (SCI-Expanded, Scopus)

16. The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma

Ilhan O., Cengiz Seval G., Civriz Bozdag S., Toprak S. K., Kurt Yuksel M., Topcuoglu P., et al.
BLOOD , cilt.138, 2021 (SCI-Expanded, Scopus)

17. Relaps Refrakter Hodgkin Lenfomada Brentuksimab Vedotin Kullanımı: Tek Merkez Deneyimi

Koyun D., Cengiz Seval G., Sökmen M., Akkuş E., Atilla E., Civriz Bozdağ S., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.5, sa.1, ss.1-4, 2021 (TRDizin)

18. Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients

Kircali E., Seval G. C., Bozdag S. C., Yuksel M. K., Topcuoglu P., Arslan O., et al.
Transplantation and Cellular Therapy , cilt.27, sa.3, ss.271, 2021 (Scopus)

19. Comparative Analysis and Validation of CIBMTR Early Relapse Risk Score with ISS and R-ISS: Single Center Experience from Ankara University

Seval G. C., Bozdag S. C., Toprak S. K., Yuksel M. K., Topcuoglu P., Arslan O., et al.
Transplantation and Cellular Therapy , cilt.27, sa.3, ss.401, 2021 (Scopus)

20. Treatment approaches for managing patients with hematological malignancies in the time of COVID-19 pandemic

CENGİZ SEVAL G., TOPÇUOĞLU P., DEMİRER T.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.6, ss.2799-2809, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

21. The Efficacy of Therapeutic Thrombocytapheresis in Patients with Thrombocytosis

NARLI ÖZDEMİR Z., ŞAHİN U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.74, 2021 (TRDizin)

22. Flamsa-based High-dose Sequential Conditioning Regimen followed by Allogeneic Hematopoietic Stem Cell Transplantation(ALLO-HSCT): Is It Effective in Patients with Primary Refractory or Relapsed Acute Leukemia?

CENGİZ SEVAL G., Kircali E., CİVRİZ BOZDAĞ S., TOPRAK S. K., Yuksel M. K., ARSLAN Ö., et al.
BONE MARROW TRANSPLANTATION , cilt.55, sa.SUPPL 1, ss.305-306, 2020 (SCI-Expanded, Scopus)

23. The Influence of anti-thymocyte Globulin(ATG) on the Outcomes of Patients with AML W/wo Measurable Residual Disease(MRD) at the time of Unrelated Donor Transplantation

CENGİZ SEVAL G., Kircali E., BALTACI M. A., CİVRİZ BOZDAĞ S., Yuksel M. K., TOPÇUOĞLU P., et al.
BONE MARROW TRANSPLANTATION , cilt.55, sa.SUPPL 1, ss.204, 2020 (SCI-Expanded, Scopus)

24. Treatment of Thrombocytopenia after Allogeneic Stem Cell Transplantation with Eltrombopag

Kircali E., CENGİZ SEVAL G., KOYUN D., Ozturk C., Uslu A., CİVRİZ BOZDAĞ S., et al.
BONE MARROW TRANSPLANTATION , cilt.55, sa.SUPPL 1, ss.410-411, 2020 (SCI-Expanded, Scopus)

25. Role of Chimerism and flow-cytometric Monitoring of Measurable Residual Disease(MRD) after Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT) in Predicting Relapse in Acute Myeloid Leukemia(AML)

CENGİZ SEVAL G., Ulas E. B., TOPRAK S. K., CİVRİZ BOZDAĞ S., Yuksel M. K., TOPÇUOĞLU P., et al.
BONE MARROW TRANSPLANTATION , cilt.55, sa.SUPPL 1, ss.192-193, 2020 (SCI-Expanded, Scopus)

26. Bir Nakil Merkezinin 11 YıllıkAllojeneik Kök Hücre Nakli Deneyimi

Kırcalı E., SEVAL G. C., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
LLM Dergi , cilt.4, sa.3, ss.50-54, 2020 (TRDizin)

27. Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation

Atilla P. A., AKKUŞ E., Atilla E., Gökmen İnan N., CİVRİZ BOZDAĞ S., Yuksel M. K., et al.
CLINICAL TRANSPLANTATION , cilt.34, sa.10, 2020 (SCI-Expanded, Scopus)

28. Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation

Atilla P. A., Akkus E., Atilla E., Gokmen N., Bozdag S. C., TOPRAK S. K., et al.
TRANSFUSION CLINIQUE ET BIOLOGIQUE , cilt.27, sa.3, ss.115-121, 2020 (SCI-Expanded, Scopus)

29. Our Approach in Allogeneic Stem CellTransplantation: 11 Years of Experience

Kırcalı E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.4, sa.3, ss.50-54, 2020 (TRDizin)

30. Allogeneic hematopoietic stem cell transplantation for primary myelofibrosis: A single-center experience.

Demirer T., Cengiz Seval G., Civriz Bozdag S., Toprak S. K., Kurt Yuksel M., Topcuoglu P., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.38, sa.15_suppl, ss.19522, 2020 (SCI-Expanded, Scopus)

31. Our Treatment Approach to Hairy Cell Leukemia

ATACA ATİLLA P., ATİLLA E., KIRCALI E., TOPÇUOĞLU P., DEMİRER T., ARSLAN Ö., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.73, sa.1, ss.5-8, 2020 (TRDizin)

32. Tüylü Hücreli Lösemide Tedavi Yaklaşımımız

ATACA ATİLLA P., ATİLLA E., Kırcalı E., TOPÇUOĞLU P., DEMİRER T., ARSLAN Ö., et al.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.73, sa.1, ss.5-8, 2020 (TRDizin)

33. Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

Seval G. C., Uslu A., Kircali E., Bozdag S. C., Toprak S. K., Yuksel M. K., et al.
Transplantation and Cellular Therapy , cilt.26, sa.3, ss.305-306, 2020 (SCI-Expanded)

34. Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

Seval G. C., Ozturk N., Bozdag S. C., Yuksel M. K., Topcuoglu P., Arslan O., et al.
Transplantation and Cellular Therapy , cilt.26, sa.3, ss.109-110, 2020 (SCI-Expanded)

35. Graft-versus-cancereffect and innovative approaches in the treatment of refractory solid tumors

Sahin U., DEMİRER T.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.50, ss.1697-1706, 2020 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

36. An uncommon presentation of diffuse large B cell lymphoma with multiple peripheral nerve involvement demonstrated BY 18F-FDG PET/CT

Araz M., Soydal Ç., Ozturk C., Özkan E., Demirer T.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.47, sa.1, ss.218-219, 2020 (SCI-Expanded, Scopus) Creative Commons License

37. Impact of Hepatitis B Core Antibody Seropositivity on the Liver Function Tests After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Cengiz Seval G., Karaman Z., Civriz Bozdağ S., Yüksel M., Topçuoğlu P., Arslan Ö., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.3, sa.3, ss.55-59, 2019 (TRDizin) Creative Commons License Sürdürülebilir Kalkınma

38. Negative Impact of High LDH at Diagnosis on OS, But Not PFS, Can Be Overcome by Autologous Stem Cell Transplantation

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.19, sa.10, 2019 (SCI-Expanded, Scopus)

39. Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?

Ilhan O., Cengiz Seval G., Toprak S. K., Civriz Bozdag S., Yuksel M. K., Topcuoglu P., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.37, sa.15_suppl, ss.19524, 2019 (SCI-Expanded, Scopus)

40. Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.

Demirer T., Cengiz Seval G., Toprak S. K., Civriz Bozdag S., Yuksel M. K., Topcuoglu P., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.37, sa.15_suppl, ss.19532, 2019 (SCI-Expanded, Scopus)

41. Influence of Conditioning Regimens with Total Body Irradiation (TBI) on Graft Versus Host Disease and Graft Versus Leukemia Effect Following Donor Lymphocyte Infusions (DLI)

Seval G. C., Atilla E., Ulas B., Bozdag S. C., Toprak S. K., Yuksel M. K., et al.
Transplantation and Cellular Therapy , cilt.25, sa.3, ss.176-177, 2019 (SCI-Expanded)

42. Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

Atilla E., Topcuoglu P., Akkus E., Atilla P. A., Bozdag S. C., Yuksel M. K., et al.
Transplantation and Cellular Therapy , cilt.25, sa.3, ss.322, 2019 (SCI-Expanded)

43. Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation

Atilla E., Atilla P. A., CENGİZ SEVAL G., Bektas M., DEMİRER T.
TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.30, sa.2, ss.122-131, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

44. The Impact of Pre-transplant Serum Ferritin on Outcomes of Allogeneic Transplantation for Acute Leukemia

ŞAHİN U., ERDAL H., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.3, sa.1, ss.9-13, 2019 (Hakemli Dergi)

45. Akut Lösemide Allojeneik Nakil Öncesi Serum Ferritin Düzeyinin Nakil Sonuçlarına Etkisi

ŞAHİN U., HASAN E., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.
Lösemi Lenfoma Miyelom Hastaları ve Araştırma Eğitimi Birliği Dergisi , cilt.3, sa.1, ss.1-3, 2019 (TRDizin)

46. Contemporary patient-tailored treatment strategies against high risk and relapsed or refractory multiple myeloma

Uckun F. M., Qazi S., DEMİRER T., Champlin R. E.
EBIOMEDICINE , cilt.39, ss.612-620, 2019 (SCI-Expanded, Scopus) Creative Commons License

47. Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience

Topcuoglu P., Cengiz Seval G., Civriz Bozdag S., Toprak S. K., Kurt Yuksel M., Dalva K., et al.
BLOOD , cilt.132, sa.Supplement 1, ss.5776, 2018 (SCI-Expanded, Scopus)

48. Clinical Reflection of Immunophenotyping in Paroxysmal Nocturnal Hemoglobinuria: Experience af a Single Center

ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., DALVA K., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , cilt.2, sa.4, ss.93-97, 2018 (TRDizin)

49. Is there a role of high dose chemotherapy and autologous stem cell transplantation in the treatment of Ewing's sarcoma and osteosarcomas?

Karadurmus N., Sahin U., Basgoz B. B., DEMİRER T.
JOURNAL OF BUON , cilt.23, sa.5, ss.1235-1241, 2018 (SCI-Expanded, Scopus)

50. Primer Mediastinal Büyük BHücreli Lenfoma HastalarımızınTedavi Sonuçlarının Geriye DönükDeğerlendirilmesi

ATİLLA E., ATACA ATİLLA P., Cengiz Seval G., TOPRAK S. K., İLHAN O., ARSLAN Ö., et al.
Türkiye’de Lösemi Lenfoma Miyelom Araştırmaları , cilt.2, sa.3, ss.60-64, 2018 (TRDizin)

51. Current strategies for the management of autologous peripheral blood stem cell mobilization failures in patients with multiple myeloma

Sahin U., DEMİRER T.
JOURNAL OF CLINICAL APHERESIS , cilt.33, sa.3, ss.357-370, 2018 (SCI-Expanded, Scopus)

52. Retrospective analysis of 115 unselected patients with mantle cell lymphoma: Single center experience.

CENGİZ SEVAL G., Bulat B., Ozel F., Tasci O., KUZU I., CİVRİZ BOZDAĞ S., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.36, sa.15, 2018 (SCI-Expanded, Scopus)

53. Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experiencea

ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
Hematology Oncology and Stem Cell Therapy , cilt.11, sa.1, ss.13-17, 2018 (Scopus)

54. Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation

CENGİZ SEVAL G., TOPÇUOĞLU P., DEMİRER T.
BALKAN MEDICAL JOURNAL , cilt.35, sa.2, ss.131-140, 2018 (SCI-Expanded, Scopus, TRDizin)

55. Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experience.

Atilla P. A., Atilla E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
Hematology/oncology and stem cell therapy , cilt.11, sa.1, ss.13-17, 2018 (Scopus)

56. Age is Not an Important Factor for Autologous Peripheral Hematopoietic Stem Cell Mobilization and Collection in Patients with Multiple Myeloma

Ilhan O., Seval G. C., Toprak S. K., Bozdag S. C., Yuksel M. K., Topcuoglu P., et al.
Transplantation and Cellular Therapy , cilt.24, sa.3, ss.142, 2018 (SCI-Expanded)

57. Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients?

Atilla E., Yalciner M., Ailla P. A., Ates C., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
ANTIVIRAL THERAPY , cilt.23, sa.8, ss.647-653, 2018 (SCI-Expanded, Scopus)

58. A review of allogeneic hematopoietic stem cell transplantation in metastatic breast cancer

Karadurmus N., Sahin U., Basgoz B. B., Arpaci F., DEMİRER T.
International Journal of Hematology-Oncology and Stem Cell Research , cilt.12, sa.2, ss.111-116, 2018 (Scopus) Sürdürülebilir Kalkınma

59. Adult Stem Cells and Medicine

CİVRİZ BOZDAĞ S., YÜKSEL M., DEMİRER T.
CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 1: STEM CELLS IN REGENERATIVE MEDICINE: ADVANCES AND CHALLENGES , cilt.1079, ss.17-36, 2018 (SCI-Expanded, Scopus)

60. Extracorporeal photochemotherapy in mycosis fungoides

Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., Topcuoglu P., et al.
TRANSFUSION CLINIQUE ET BIOLOGIQUE , cilt.24, sa.4, ss.454-457, 2017 (SCI-Expanded, Scopus)

61. A review of late complications of allogeneic hematopoietic stem cell transplantations

Atilla E., Atilla P. A., TOPRAK S. K., DEMİRER T.
CLINICAL TRANSPLANTATION , cilt.31, sa.10, 2017 (SCI-Expanded, Scopus)

62. A review of infectious complications after haploidentical hematopoietic stem cell transplantations

Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., DEMİRER T.
INFECTION , cilt.45, sa.4, ss.403-411, 2017 (SCI-Expanded, Scopus)

63. Subsequent malignancies after allogeneic hematopoietic stem cell transplantation

Gunduz M., Ozen M., Sahin U., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
CLINICAL TRANSPLANTATION , cilt.31, sa.7, 2017 (SCI-Expanded, Scopus)

64. How to manage poor mobilizers for high dose chemotherapy and autologous stem cell transplantation?

Atilla P. A., Ozturk S. M. B., DEMİRER T.
TRANSFUSION AND APHERESIS SCIENCE , cilt.56, sa.2, ss.190-198, 2017 (SCI-Expanded, Scopus)

65. An overview of high dose chemotherapy with autologous stem cell rescue for germ cell tumors in current practice

Ozaydin S., Sahin U., Karadurmus N., Arpaci F., DEMİRER T.
JOURNAL OF BUON , cilt.22, sa.2, ss.306-311, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

66. Catheter Thrombosis in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) Recipients

GÜRMAN G., Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., Yuksel M. K., TOPRAK S. K., et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , cilt.23, sa.3, 2017 (SCI-Expanded) Creative Commons License

67. Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?

Atilla E., Atilla P. A., DEMİRER T.
INTERNATIONAL JOURNAL OF HEMATOLOGY , cilt.105, sa.3, ss.257-264, 2017 (SCI-Expanded, Scopus)

68. Re: Iron overload in hematopoietic stem cell transplantation Re: Hematopoetik kök hücre transplantasyonunda aşırı demir yüklenmesi

Atilla E., TOPRAK S. K., DEMİRER T.
Turkish Journal of Hematology , cilt.34, sa.1, ss.103, 2017 (SCI-Expanded, Scopus, TRDizin)

69. Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental Study

Ozen M., Ustun C., Ozturk B., TOPÇUOĞLU P., Arat M., Gunduz M., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.16-26, 2017 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

70. A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations

Atilla E., Atilla P. A., DEMİRER T.
BALKAN MEDICAL JOURNAL , cilt.34, sa.1, ss.1-9, 2017 (SCI-Expanded, Scopus, TRDizin)

71. Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation

Atilla E., TOPRAK S. K., DEMİRER T.
TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.1-9, 2017 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

72. Iron Overload in Hematopoietic Stem Cell Transplantation Reply

Atilla E., TOPRAK S. K., Demirer T.
TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.103, 2017 (SCI-Expanded, Scopus, TRDizin)

73. Preface

DEMİRER T.
Stem Cell Biology and Regenerative Medicine , cilt.Part F4903, 2017 (Scopus)

74. Hairy Cell Leukemia Presenting with Isolated Bone Lesions

GÜNDÜZ M., ÖZEN M., YÜKSEL S., KUZU I., DEMİRER T.
LLM Dergi , cilt.1, sa.1, ss.14-17, 2017 (TRDizin)

75. Therapeutic Plasma Exchange for Thrombotic Microangiopathy

Ilhan O., Atilla E., Ataca Atilla P., Civriz Bozdag S., Kurt Yuksel M., Toprak S. K., et al.
BLOOD , cilt.128, sa.22, ss.4939, 2016 (SCI-Expanded, Scopus)

76. An overview of hematopoietic stem cell transplantation related thrombotic complications

Sahin U., Atilla P. A., Atilla E., TOPRAK S. K., DEMİRER T.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , cilt.107, ss.149-155, 2016 (SCI-Expanded, Scopus)

77. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation

Sahin U., TOPRAK S. K., Atilla P. A., Atilla E., DEMİRER T.
JOURNAL OF INFECTION AND CHEMOTHERAPY , cilt.22, sa.7-8, ss.505-514, 2016 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

78. High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Breast Cancer: Is There Still a Hope?

DEMİRER T.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.3, ss.182-187, 2016 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

79. Non-Infectious Early Complications of Allogeneic Stem Cell Transplantations

Atilla P. A., Atilla E., TOPRAK S. K., DEMİRER T.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.4, ss.239-250, 2016 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

80. Review of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in solid tumors excluding breast cancer

KARADURMUS N., ŞAHİN U., BASGOZ B. B., ARPACI F., DEMİRER T.
World Journal of Transplantation , cilt.6, sa.4, ss.675-681, 2016 (Hakemli Dergi)

81. A Quasi-Experimental Study Analyzing the Effectiveness of Portable High-Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction

Ozen M., Yilmaz G., Coskun B., TOPÇUOĞLU P., Ozturk B., Gunduz M., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.1, ss.41-47, 2016 (SCI-Expanded, Scopus, TRDizin)

82. Comparison of Two Different Doses of Corticosteroid Premedication for Antithymocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation

Merter M., Atilla E., Sahin U., Civriz Bozdag S., Kurt Yuksel M., Topcuoglu P., et al.
BLOOD , cilt.126, sa.23, ss.5456, 2015 (SCI-Expanded, Scopus)

83. Positive Impact of Chronic Graft-Versus Host Disease on Survival in 928 Allogeneic Hematopoietic Stem Cell Transplant Recipients

Gurman G., Ataca P., Atilla E., Civriz Bozdag S., Toprak S. K., Yuksel M. K., et al.
BLOOD , cilt.126, sa.23, ss.1952, 2015 (SCI-Expanded, Scopus)

84. Is Initial CD3+ T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?

Atilla E., Ataca P., Toprak S. K., Yuksel M. K., Topcuoglu P., Arslan O., et al.
BLOOD , cilt.126, sa.23, ss.5483, 2015 (SCI-Expanded, Scopus)

85. Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation

Martino M., Lanza F., DEMİRER T., Moscato T., Secondino S., Pedrazzoli P.
EXPERT OPINION ON BIOLOGICAL THERAPY , cilt.15, sa.2, ss.195-211, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

86. Antilymphocyte/Thymocyte Globulin for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease: 20-Year Experience at a Single Center

Ozen M., CİVRİZ BOZDAĞ S., Cakmak G., TOPÇUOĞLU P., Eroglu A. H., Glunduz M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.25, sa.4, ss.236-244, 2015 (SCI-Expanded, Scopus, TRDizin)

87. Is the Chronic Myeloproliferative Disease Prognosis Really Different in Geriatric Patients?

Ilhan O., Ataca P., Atilla E., Toprak S. K., Kaygusuz G., Kuzu I., et al.
BLOOD , cilt.124, sa.21, ss.5555, 2014 (SCI-Expanded, Scopus)

88. Clinical Reflection of Immunophenotyping in Paroxysmal Nocturnal Hemoglobinuria: Experience of a Single Center

Sahin U., Merter M., Ataca P., Atilla E., Atesagaoglu B., Pekcan G., et al.
BLOOD , cilt.124, sa.21, ss.5150, 2014 (SCI-Expanded, Scopus)

89. Fertility in Our Allogeneic Hematopoietic Stem Cell Transplant Patients

Topcuoglu P., Ataca P., Bozdag S. C., Toprak S. K., Arslan O., Ozcan M., et al.
BLOOD , cilt.124, sa.21, ss.5887, 2014 (SCI-Expanded, Scopus)

90. Do FMS-like Tyrosine Kinase 3 and Nucleophospmin 1 Gene Mutations Really Effect Survival in Acute Myeloid Leukemia ?

Gunduz M., Ataca P., Ozen M., Atilla E., Bozdag S. C., Toprak S. K., et al.
BLOOD , cilt.124, sa.21, ss.5328, 2014 (SCI-Expanded, Scopus)

91. Is R-CODOX-M/IVAC Inferior to Other Regimens in Burkitt’s Lymphoma: A Single Center Experience

Atilla E., Sahin U., Ataca P., Uslu A., Kircali E., Atesagaoglu B., et al.
BLOOD , cilt.124, sa.21, ss.5448, 2014 (SCI-Expanded, Scopus)

92. Treatment Approaches in Acute Leukemia Patients Relapsing Following Allogeneic Hematopoietic Stem Cell Transplantation

Topcuoglu P., Gunduz M., Ozen M., Civriz Bozdag S., Kocak Toprak S., Arslan O., et al.
BLOOD , cilt.124, sa.21, ss.5891, 2014 (SCI-Expanded, Scopus)

93. Autologous stem cell transplantation: is it still relevant in breast cancer?

Pedrazzoli P., Bregni M., Rosti G., Lanza F., DEMİRER T.
BREAST CANCER MANAGEMENT , cilt.2, sa.6, ss.447-450, 2013 (ESCI, Scopus) Sürdürülebilir Kalkınma

94. Response to: 'Are there still reasons to believe that high-dose chemotherapy plays a role in breast cancer management?'

DEMİRER T.
Bone Marrow Transplantation , cilt.48, sa.2, ss.306, 2013 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

95. Intense Ga-68 Dotatate Uptake in Recurrent MTC Patient

SOYDAL Ç., ÖZKAN E., ARAZ M., KÜÇÜK N. Ö., DEMİRER T.
World Journal of Endocrine Surgery , cilt.4, sa.3, ss.118-119, 2012 (Scopus) Creative Commons License

96. Novel agents and approaches for stem cell mobilization in normal donors and patients

Bakanay Ş., DEMİRER T.
Bone Marrow Transplantation , cilt.47, sa.9, ss.1154-1163, 2012 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

97. Is adoptive T-cell therapy for solid tumors coming of age

Pedrazzoli P., Comoli P., Montagna D., DEMİRER T., Bregni M.
Bone Marrow Transplantation , cilt.47, sa.8, ss.1013-1019, 2012 (SCI-Expanded, Scopus)

98. Intense ga-68 dotatate uptake in recurrent mtc patients

SOYDAL Ç., ÖZKAN E., ARAZ M., KÜÇÜK N. Ö., DEMİRER T.
WORLD JOURNAL OF ENDOCRINE SURGERY , cilt.4, sa.3, ss.118-119, 2012 (Scopus)

99. High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: Overview of 15 randomized trials

Berry D. A., Ueno N. T., Johnson M. M., Lei X., Caputo J., Rodenhuis S., et al.
Journal of Clinical Oncology , cilt.29, sa.24, ss.3214-3223, 2011 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

100. High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: Overview of six randomized trials

Berry D. A., Ueno N. T., Johnson M. M., Lei X., Caputo J., Smith D. A., et al.
Journal of Clinical Oncology , cilt.29, sa.24, ss.3224-3231, 2011 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

101. Allogeneic hematopoietic stem cell transplantation in ovarian cancer - The EBMT experience

Bay J., Cabrespine-Faugeras A., Tabrizi R., Blaise D., Viens P., Ehninger G., et al.
International Journal of Cancer , cilt.127, sa.6, ss.1446-1452, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

102. Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: a randomized evaluation of early vs late administration of recombinant human G-CSF

Ozcelik T., Topcuoglu P., BEKSAÇ M., Ozcan M., Arat M., Biyikli Z., et al.
BONE MARROW TRANSPLANTATION , cilt.44, sa.12, ss.779-783, 2009 (SCI-Expanded, Scopus) Creative Commons License

103. HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT VERSUS STANDARD-DOSE CHEMOTHERAPY: META-ANALYSIS OF INDIVIDUAL PATIENT DATA FROM 6 RANDOMIZED METASTATIC BREAST CANCER TRIALS

Pedrazzoli P., DEMİRER T., Berry D. A., Bregni M.
ANNALS OF ONCOLOGY , cilt.20, 2009 (SCI-Expanded, Scopus)

104. Severe Henoch-Schonlein Purpura Induced by Cytarabine

Aktas B., TOPÇUOĞLU P., Kurt O. K., ENSARİ A., Demirer T.
ANNALS OF PHARMACOTHERAPY , cilt.43, sa.4, ss.792-793, 2009 (SCI-Expanded, Scopus)

105. Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Colorectal Cancer as a Novel Adoptive Cell Therapy Approach. The European Group for Blood and Marrow Transplantation Experience

Aglietta M., Barkholt L., Schianca F. C., Caravelli D., Omazic B., Minotto C., et al.
Biology of Blood and Marrow Transplantation , cilt.15, sa.3, ss.326-335, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

106. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloblastic leukemia (AML): A single center experience

İLHAN O., TOPÇUOĞLU P., Arat M., Soydan E. A., YÜKSEL M., ARSLAN Ö., et al.
Turkish Journal of Hematology , cilt.25, sa.2, ss.87-93, 2008 (SCI-Expanded, Scopus, TRDizin)

107. 28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures

Ladenstein R., Poetschger U., Hartman O., Pearson A. D. J., Klingebiel T., Castel V., et al.
BONE MARROW TRANSPLANTATION , cilt.41, 2008 (SCI-Expanded, Scopus) Creative Commons License

108. Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors

DEMİRER T., Barkholt L., Blaise D., Pedrazzoli P., Aglietta M., Carella A. M., et al.
NATURE CLINICAL PRACTICE ONCOLOGY , cilt.5, sa.5, ss.256-267, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

109. Allogeneic hematopoietic cell transplantation for metastatic breast cancer

Ueno N. T., Rizzo J. D., Demirer T., Cheng Y. C., Hegenbart U., Zhang M., et al.
BONE MARROW TRANSPLANTATION , cilt.41, sa.6, ss.537-545, 2008 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

110. High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: The experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working Party

De Giorgi U., Blaise D., Lange A., Viens P., Marangolo M., Madroszyk A., et al.
BONE MARROW TRANSPLANTATION , cilt.40, sa.11, ss.1045-1048, 2007 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

111. High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults

Pedrazzoli P., Rosti G., Secondino S., Carminati O., Demirer T.
SEMINARS IN HEMATOLOGY , cilt.44, sa.4, ss.286-295, 2007 (SCI-Expanded, Scopus)

112. Does high-dose carmustine increase overall survival in supratentorial high-grade malignant glioma? An EBMT retrospective study

Jacques-Olivier B., Claude L., Pierre B., Xavier D., Pierre V., Fabrice K., et al.
INTERNATIONAL JOURNAL OF CANCER , cilt.120, sa.8, ss.1782-1786, 2007 (SCI-Expanded, Scopus)

113. Reduced intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow Transplantation

Secondino S., Carrabba M. G., Pedrazzoli P., Castagna L., Spina F., Grosso F., et al.
HAEMATOLOGICA , cilt.92, sa.3, ss.418-420, 2007 (SCI-Expanded, Scopus)

114. High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults

Pedrazzoli P., Ledermann J. A., Lotz J. -., Leyvraz S., Aglietta M., Rosti G., et al.
ANNALS OF ONCOLOGY , cilt.17, sa.10, ss.1479-1488, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

115. Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

Barkholt L., Bregni M., Remberger M., Blaise D., Peccatori J., Massenkeil G., et al.
ANNALS OF ONCOLOGY , cilt.17, sa.7, ss.1134-1140, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

116. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

Ljungman P., Urbano-Ispizua A., Cavazzana-Calvo M., Demirer T., Dini G., Einsele H., et al.
BONE MARROW TRANSPLANTATION , cilt.37, sa.5, ss.439-449, 2006 (SCI-Expanded, Scopus) Creative Commons License

117. Retrospective validation of an apheresis cycle calculator on autologous PBSC collection in myeloma and malignant lymphoma patients.

Arat M., Soydan E., Cengiz G., Ayyildiz E., Topcuoglu P., Arslan O., et al.
CYTOTHERAPY , cilt.8, 2006 (SCI-Expanded, Scopus)

118. Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation

Peccatori J., Barkholt L., Demirer T., Sormani M., Bruzzi P., Ciceri F., et al.
CANCER , cilt.104, sa.10, ss.2099-2103, 2005 (SCI-Expanded, Scopus)

119. Allogeneic hematopoletic cell transplantation for metastatic breast cancer

Naoto U., Rizzo D., Demirer T., Cheng Y. C., Hegenbart U., Zhang M., et al.
EJC SUPPLEMENTS , cilt.3, sa.2, ss.131, 2005 (SCI-Expanded, Scopus)

120. Non-myeloablative transplantation in solid tumors-results in other solid tumors

Demirer T.
EJC SUPPLEMENTS , cilt.3, sa.2, ss.36, 2005 (SCI-Expanded, Scopus)

121. Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours

De Giorgi U., Rosti G., Slavin S., Yaniv I., Harousseau J., Ladenstein R., et al.
BRITISH JOURNAL OF CANCER , cilt.93, sa.4, ss.412-417, 2005 (SCI-Expanded, Scopus) Creative Commons License

122. High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)

Bengala C., Guarneri V., Ledermann J., Rosti G., Wandt H., Lotz J., et al.
BONE MARROW TRANSPLANTATION , cilt.36, sa.1, ss.25-31, 2005 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

123. Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience

De Giorgi U., Demirer T., Wandt H., Taverna C., Siegert W., Bornhauser M., et al.
ANNALS OF ONCOLOGY , cilt.16, sa.1, ss.146-151, 2005 (SCI-Expanded, Scopus)

124. First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working Party

Rosti G., De Giorgi U., Wandt H., Lioure B., Leyvraz S., Kolbe K., et al.
BONE MARROW TRANSPLANTATION , cilt.34, sa.12, ss.1033-1037, 2004 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

125. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - A retrospective evaluation

Demirer T., Ayli M., Fen T., Ozcan M., Arat M., Buyukberber S., et al.
Bone Marrow Transplantation , cilt.34, sa.9, ss.781-786, 2004 (SCI-Expanded, Scopus) Creative Commons License

126. The Comparison of Myeloablative Versus Reduced Intensity Conditioning Regimen in ABO Mismatched Allogeneic Hematopoietic Cell Transplantation.

Topcuoglu P., Arat M., Bolukbasi T., Soydan E., Ozer Y., Ozcan M., et al.
BLOOD , cilt.104, sa.11, ss.5146, 2004 (SCI-Expanded, Scopus)

127. Allogeneic Hemapoietic Progenitor Cell Collection Using Four Different Cell Separators: A Retrospective Comparative Analysis.

Arat M., Arslan O., Soydan E. A., Ayyildiz E., Dalva K., Tol M., et al.
BLOOD , cilt.104, sa.11, ss.5009, 2004 (SCI-Expanded, Scopus)

128. Hematopoetic stem cell transplantation for solid tumors in Europe

Gratwohl A., Baldomero H., Demirer T., Rosti G., Dini G., Ladenstein R., et al.
ANNALS OF ONCOLOGY , cilt.15, sa.4, ss.653-660, 2004 (SCI-Expanded, Scopus)

129. LONG-TERM RESULTS WITH HIGH-DOSE CHEMOTHERAPY IN ADULT PATIENTS WITH EXTRAGONADAL GERM CELL TUMORS: THE EXPERIENCE OF THE EUROPEAN BONE MARROW TRANSPLANTATION (EBMT) SOLID TUMOURS WORKING PARTY

Demirer T., De Giorgi U., Papiani G., Rosti G.
ANNALS OF ONCOLOGY , cilt.15, ss.97, 2004 (SCI-Expanded, Scopus)

130. Second-line high-dose chemotherapy in patients with extragonadial nonseminomatous germ cell tumors: the experience of the European Group for Blood and Marrow Transplantation (EBMT)

De Giorgi U., DEMİRER T., Wandt H., Taverna C., Siegert W., Borhauser M., et al.
ANNALS OF ONCOLOGY , cilt.15, ss.121, 2004 (SCI-Expanded, Scopus)

131. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients

Kroger N., Damon L., Zander A., Wandt H., Derigs G., Ferrante P., et al.
BONE MARROW TRANSPLANTATION , cilt.32, sa.12, ss.1153-1157, 2003 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

132. Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999

Pedrazzoli P., Ferrante P., Kulekci A., Schiavo R., De Giorgi U., Carminati O., et al.
BONE MARROW TRANSPLANTATION , cilt.32, sa.5, ss.489-494, 2003 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

133. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation

Demirer T., Uysal V., Ayli M., Genc Y., Ilhan O., Koc H., et al.
BONE MARROW TRANSPLANTATION , cilt.31, sa.9, ss.755-761, 2003 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

134. Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation

Kroger N., Zander A., Martinelli G., Ferrante P., Moraleda J., Da Prada G., et al.
ANNALS OF ONCOLOGY , cilt.14, sa.4, ss.554-558, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

135. CD34+cells in hematopoietic stem cell transplantation

Demirer T.
TISSUE ENGINEERING, STEM CELLS AND GENE THERAPIES , cilt.534, ss.107-118, 2003 (SCI-Expanded, Scopus)

136. CD34+ cells in hematopoietic stem cell transplantation

DEMİRER T.
Advances in Experimental Medicine and Biology , cilt.534, ss.107-118, 2003 (Scopus)

137. The role of ABO incompatibility in allogeneic peripheral blood stem cell transplantation

ARSLAN Ö., Coşkun H. Ş., Arat M., Soydan E., ÖZCAN M., GÜRMAN G., et al.
Turkish Journal of Haematology , cilt.19, sa.3, ss.401-409, 2002 (SCI-Expanded, Scopus, TRDizin)

138. The effect of post-transplant spironolactone on daily potassium requirements in patients undergoing autologous stem cell transplantation

Demirer T., Ayli M., Dagli M., Fen T., Haznedar R., Ustael N., et al.
BONE MARROW TRANSPLANTATION , cilt.30, sa.10, ss.703-704, 2002 (SCI-Expanded, Scopus) Creative Commons License

139. Monitoring of peripheral blood CD34+cell counts on the first day of apheresis is highly predictive for efficient CD34+cell yield

Demirer T., Ilhan O., Ayli M., Arat M., Dagli M., Ozcan M., et al.
THERAPEUTIC APHERESIS , cilt.6, sa.5, ss.384-389, 2002 (SCI-Expanded)

140. The Role of ABO Incompatibility in Allogeneic Peripheral Blood Stem Cell Transplant.

Arslan Ö., Coşkun H. Ş., Arat M., Soydan E., Özcan M., Gürman G., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.19, sa.3, ss.401-9, 2002 (Scopus, TRDizin)

141. Influence of post-transplant recombinant human granulocyte colony-stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation.

Demirer T., Ayli M., Dagli M., Haznedar R., Genc Y., Fen T., et al.
British journal of haematology , cilt.118, sa.4, ss.1104-11, 2002 (SCI-Expanded, Scopus)

142. A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters

Demirer T., Dagli M., Ilhan O., Ayli M., Haznedar R., Fen T., et al.
BONE MARROW TRANSPLANTATION , cilt.29, sa.11, ss.893-897, 2002 (SCI-Expanded, Scopus) Creative Commons License

143. The EBMT solid tumors working party (STWP) registry: 2001 report

Demirer T.
BONE MARROW TRANSPLANTATION , cilt.29, 2002 (SCI-Expanded, Scopus)

144. High-dose chemotherapy (HDC) with autologous hemopoeitic support for advanced ovarian cancer in 1st complete remission: retrospective analysis from Solid Tumor Registry of the European Group for Blood and Marrow Transplantation

Bengala C., Guarneri V., Ledermann J., Wandt H., Lotz J., Cure J., et al.
BONE MARROW TRANSPLANTATION , cilt.29, 2002 (SCI-Expanded, Scopus)

145. Does donor recipient ABO-incompatibility have any effect on the course and outcome of allogeneic hematopoietic cell transplantation?

Arslan O., Arat M., Soydan E., COŞKUN H. Ş., Topcuoglu P., Ozcan M., et al.
BONE MARROW TRANSPLANTATION , cilt.29, 2002 (SCI-Expanded, Scopus)

146. Influence of post-transplant granulocyte-colony stimulating factor (G-Csf) administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation (Asct)

Demirer T., Ayly M., Dagly M., Genc Y., Fen T., Dincer S., et al.
BONE MARROW TRANSPLANTATION , cilt.29, 2002 (SCI-Expanded, Scopus)

147. Low incidence of secondary myelodysplasia (sMDS) and acute myeloid leukemia (sAML) after high-dose chemotherapy as adjuvant therapy for breast cancer patients

Kröger N., Zander A., Ferrante P., Martinelli G., Janvier M., Moraleda J., et al.
BONE MARROW TRANSPLANTATION , cilt.29, 2002 (SCI-Expanded, Scopus)

148. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF

Demirer T., Ayli M., Ozcan M., Gunel N., Haznedar R., Dagli M., et al.
BRITISH JOURNAL OF HAEMATOLOGY , cilt.116, sa.2, ss.468-474, 2002 (SCI-Expanded, Scopus)

149. Plasmacytoma in the bilateral breast

Daǧli M., DEMİRER T., Ayli M., Haznedar R., GÜNEL N., Sucak G., et al.
Turkish Journal of Haematology , cilt.19, sa.4, ss.481-483, 2002 (SCI-Expanded, Scopus, TRDizin)

150. An unusual presentation of plasma cell dyscrasias: cardiac tamponade due to myelomatous infiltration.

Arat M., Ulusoy V., Demirer T., Uysal A., Ozcan M., Dincer S., et al.
Leukemia & lymphoma , cilt.43, sa.1, ss.145-8, 2002 (SCI-Expanded)

151. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte-colony stimulating factor (rh-GSCF): A randomized evaluation of different doses of rh-G-CSF.

Demirer T., Ayli M., Arat M., Ozcan M., Gunel N., Haznedar R., et al.
BLOOD , cilt.98, sa.11, 2001 (SCI-Expanded, Scopus)

152. A randomized trial of assessment of efficacy of leukapheresis volumes, 8 L versus 10L.

Demirer T., Ayli M., Arat M., Gunel N., Ozcan M., Haznedar R., et al.
BLOOD , cilt.98, sa.11, 2001 (SCI-Expanded, Scopus)

153. CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation

DEMİRER T., Ilhan O., Arat M., YAVUZ Y., ÖZCAN M. E., DALVA K., et al.
Journal of Clinical Apheresis , cilt.16, sa.2, ss.67-73, 2001 (SCI-Expanded, Scopus)

154. Recombinant human granulocyte colony-stimulating factor (rh-G-CSF) may accelerate hematopoietic recovery after HLA-identical sibling allogeneic peripheral blood stem cell transplantation

Ozcan M., Ustun C., Akcaglayan E., Akan H., Arslan O., Ilhan O., et al.
BONE MARROW TRANSPLANTATION , cilt.27, sa.5, ss.499-505, 2001 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

155. High-dose Thiotepa, Melphalan and Carboplatin (TMCB) with autologous Peripheral Blood Stem Cell (PBSC) support in patients with hematologic malignancies and solid tumors

Demirer T., Ilhan O., Ayli M., Arat M., Fen T., Ozcan M., et al.
BONE MARROW TRANSPLANTATION , cilt.27, 2001 (SCI-Expanded, Scopus)

156. CD41+and CD42+hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation

Demirer T., Ilhan O., Arat M., Genc Y., Ozcan M., Dalva K., et al.
JOURNAL OF CLINICAL APHERESIS , cilt.16, sa.2, ss.67-73, 2001 (SCI-Expanded, Scopus)

157. Peripheral blood stem cell (PBSC) collection with cyclophosphamide (CY), epirubicin and recombinant human granulocyte-colony stimulating factor (rhG-CSF) in patients with breast and ovarian cancer.

Demirer T., Ayli M., Demirer A., Ulusoy V., Fen T., Celik Z., et al.
BLOOD , cilt.96, sa.11, 2000 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

158. Peripheral blood stem cell (PBSC) collection with cyclophosphamide (CY), etoposide and recombinant human granulocyte-colony stimulating factor (rhG-CSF) in patients with hematologic malignancies and solid tumors.

Demirer T., Ayli M., Demirer A., Fen T., Haznedar R., Celik Z., et al.
BLOOD , cilt.96, sa.11, 2000 (SCI-Expanded, Scopus)

159. The value of peripheral blood CD34(+) cell quantification in autologous hematopoietic stem cell apheresis.

Ilhan O., Arslan O., Arat M., Ozcan M., GÜRMAN G., Dalva K., et al.
BLOOD , cilt.96, sa.11, 2000 (SCI-Expanded, Scopus)

160. Phase-II study of high-dose thiotepa, melphalan and carboplatin (TMCb) with autologous peripheral blood stem cell (PBSC) support in patients with hematologic malignancies and solid tumors.

Demirer T., Ilhan O., Ayli M., Arat M., Fen T., Haznedar R., et al.
BLOOD , cilt.96, sa.11, 2000 (SCI-Expanded, Scopus)

161. Comparison of the efficacy of medium chain triglycerides with long chain triglycerides in total parenteral nutrition in patients with hematologic malignancies undergoing peripheral blood stem cell transplantation

Demirer S., Aydintug S., Ustun C., Turkmen E., Tuzun A., Simsek S., et al.
CLINICAL NUTRITION , cilt.19, sa.4, ss.253-258, 2000 (SCI-Expanded, Scopus)

162. Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of Ibni Sina Hospital

Arslan O., COŞKUN H. Ş., Arat M., Celebi H., Ozcan M., GÜRMAN G., et al.
BONE MARROW TRANSPLANTATION , cilt.25, sa.12, ss.1229-1232, 2000 (SCI-Expanded, Scopus) Creative Commons License

163. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies

Demirer T., Ilhan O., Mandel N., Arat M., Gunel N., Celebi H., et al.
BONE MARROW TRANSPLANTATION , cilt.25, sa.7, ss.697-703, 2000 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

164. CD34+PBSC mobilization with cyclophosphamide (CY), paclitaxel and recombinant human granulocyte colony stimulating factor (Rh-GCSF) in patients with lymphoid malignancies.

Ayli M., Fen T., Demirer A., Celik Z., Oymak A., Özdel Ö., et al.
ANNALS OF ONCOLOGY , cilt.11, ss.98, 2000 (SCI-Expanded, Scopus)

165. Primary low-grade lymphomas of the intestine - Case 1: Immunoproliferative small intestinal disease

Demirer T., Celebi H., Akcaglayan E., Ustun C., Demirer S., Ekinci C., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.17, sa.11, ss.3682-3684, 1999 (SCI-Expanded, Scopus)

166. Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: A case report

Üstün C., Çelebi H., Arat M., ÖZCAN M., Dilek I., GÜRMAN G., et al.
Therapeutic Apheresis , cilt.3, sa.3, ss.275-277, 1999 (SCI-Expanded)

167. Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation

Demirer T., Celebi H., Arat M., Ustun C., Demirer S., Dilek I., et al.
BONE MARROW TRANSPLANTATION , cilt.24, sa.3, ss.335-337, 1999 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

168. Peripheral blood stem cell mobilization for high-dose chemotherapy

Demirer T., Bensinger W., Buckner C.
JOURNAL OF HEMATOTHERAPY , cilt.8, sa.2, ss.103-113, 1999 (SCI-Expanded, Scopus)

169. The effect of G-CSF in the first 100 days of allogeneic peripheral blood stem cell transplantation.

Ozcan M., Ustun C., Ilhan O., Beksac M., Akcaglayan E., GÜRMAN G., et al.
BONE MARROW TRANSPLANTATION , cilt.23, 1999 (SCI-Expanded, Scopus)

170. A protocol proposal for high-dose chemotherapy (HDC) with autologous peripheral blood stem cell transplantation (PBSCT) versus conventional chemotherapy in patients with relapsed cisplatin sensitive epithelial ovarian cancer -: 2 arm randomized study.

Demirer T., Arat M., Koç H., İLHAN ., Akan H., GÜRMAN G., et al.
BONE MARROW TRANSPLANTATION , cilt.23, 1999 (SCI-Expanded, Scopus)

171. Peripheral blood stem cell (PBSC) collection with cyclophosphamide (CY) - Paclitaxel and recombinant human granulocyte-colony stimulating factor (rhG-CSF) in patients with breast cancer: Ibni Sina experience

Arat M., Demirer T., Ilhan O., Koc H., Ustun C., Celebi H., et al.
BONE MARROW TRANSPLANTATION , cilt.23, 1999 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

172. The influence of CD41+ and CD42+ peripheral blood stem cells on platelet engraftment after allo PBSCT.

Ilhan O., Demirer T., Arat M., Dalva K., COŞKUN H. Ş., BEKSAÇ M., et al.
BONE MARROW TRANSPLANTATION , cilt.23, 1999 (SCI-Expanded, Scopus)

173. Clinical effects of intravenous immune globulin (IVIG) treatment in patients with allogeneic peripheral stem cell transplantation.

Ustun C., Ozcan M., Beksac M., Ilhan O., Cakir M., GÜRMAN G., et al.
BONE MARROW TRANSPLANTATION , cilt.23, 1999 (SCI-Expanded, Scopus)

174. Allogeneic hematopoietic cell transplantation in patients with advanced hematological malignancies by using nonmyeloablative conditioning regimen.

GÜRMAN G., Ustun C., Arslan O., BEKSAÇ M., Konuk N., Arat M., et al.
BONE MARROW TRANSPLANTATION , cilt.23, 1999 (SCI-Expanded, Scopus)

175. A protocol proposal comparing conventional approach with high-dose chemotherapy (HDC) and peripheral blood stem cell transplantation (PBSCT) in patients with small cell lung cancer limited to thorax.

Demirer T., Arat M., Koc H., Ilhan O., Celebi H., Ozcan M., et al.
BONE MARROW TRANSPLANTATION , cilt.23, 1999 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

176. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: A focus on the incidence of graft-vs.-host disease and relapse

Üstün C., ARSLAN Ö., BEKSAÇ M., Koç H., GÜRMAN G., Özçelik T., et al.
Biology of Blood and Marrow Transplantation , cilt.5, sa.1, ss.28-35, 1999 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

177. Differences in liver pathology and clinical outcome between two patients with Hepatitis B virus and graft versus host disease

Üstün C., ÖZCAN M., GÜRMAN G., Çakir M., Erekul S., AKYOL G., et al.
Pathology and Oncology Research , cilt.5, sa.3, ss.229-232, 1999 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

178. Clinical effects of intravenous immune globulin (IVIG) treatment in patients with allogeneic peripheral stem cell transplantation.

Ustun C., Ozcan M., BEKSAÇ M., Ilhan O., Cakir M., GÜRMAN G., et al.
BLOOD , cilt.92, sa.10, 1998 (SCI-Expanded, Scopus)

179. Allogeneic hematopoietic stem cell transplantation in patients with advanced hematological malignancies by using nonmyeloablative conditioning regimen.

GÜRMAN G., Ustun C., Arslan O., BEKSAÇ M., Konuk N., Arat M., et al.
BLOOD , cilt.92, sa.10, 1998 (SCI-Expanded, Scopus)

180. The effect of G-CSF in the first 100 days of allogeneic peripheral blood stem cell transplantation.

Ozcan M., Ustun C., Ilhan O., BEKSAÇ M., Akcaglayan E., GÜRMAN G., et al.
BLOOD , cilt.92, sa.10, 1998 (SCI-Expanded, Scopus)

181. Which hematopoietic stem cell transplantation type is safe for patients with hepatitis B virus carriers.

Ustun C., Idilman R., Ozcan M., Akan H., Karayalcin S., GÜRMAN G., et al.
HEPATOLOGY , cilt.28, sa.4, 1998 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

182. Acute myeloblastic leukemia associated with hyperleukocytosis and diabetes insipidus

Dilek I., Uysal A., Demirer T., Koc H., Ozcan M., Keles H., et al.
LEUKEMIA & LYMPHOMA , cilt.30, sa.5-6, ss.657-660, 1998 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

183. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia

Dilek I., Demirer T., Ustun C., Arat M., Koc H., BEKSAÇ M., et al.
BONE MARROW TRANSPLANTATION , cilt.21, sa.11, ss.1159-1161, 1998 (SCI-Expanded, Scopus) Creative Commons License

184. Tempo of hematologic recovery correlates with peripheral blood CD34+ cell level in patients undergoing stem cell mobilization

Williams O., DEMİRER T., Lilleby K., Buckner C. D., Bensinger W.
Journal of Clinical Apheresis , cilt.13, sa.1, ss.1-6, 1998 (SCI-Expanded, Scopus)

185. High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer

Holmberg L., Demirer T., Rowley S., Buckner C., Goodman G., Maziarz R., et al.
BONE MARROW TRANSPLANTATION , cilt.22, sa.7, ss.651-659, 1998 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

186. High-dose busulfan, melphalan and thiotepa (BUMELTT) followed by autologous peripheral blood stem cells (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.

Holmberg L., Demirer T., Sciffman K., Rowley S., Buckner C., Goodman G., et al.
BLOOD , cilt.90, sa.10, ss.1705, 1997 (SCI-Expanded, Scopus)

187. Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor

Demirer T., Buckner C., Storer B., Lilleby K., Rowley S., Clift R., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.15, sa.2, ss.684-690, 1997 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

188. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy

Bensinger W., Buckner C., Shannon-Dorcy K., Rowley S., Appelbaum F., Benyunes M., et al.
Blood , cilt.88, sa.11, ss.4132-4138, 1996 (Scopus) Creative Commons License

189. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation

Bensinger W., Clift R., Martin P., Appelbaum F., Demirer T., Gooley T., et al.
BLOOD , cilt.88, sa.7, ss.2794-2800, 1996 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

190. Syngeneic marrow transplantation in patients with multiple myeloma

Bensinger W., DEMİRER T., Buckner C., Appelbaum F., Storb R., Lilleby K., et al.
Bone Marrow Transplantation , cilt.18, sa.3, ss.527-531, 1996 (SCI-Expanded, Scopus)

191. Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia

DEMİRER T., Petersen F., Bensinger W., Appelbaum F., Fefer A., Rowley S., et al.
Bone Marrow Transplantation , cilt.18, sa.1, ss.29-34, 1996 (SCI-Expanded, Scopus)

192. High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: Comparison of autologous bone marrow and peripheral blood stem cells

Brunvand M., Bensinger W., Soll E., Weaver C., Rowley S., Appelbaum F., et al.
Bone Marrow Transplantation , cilt.18, sa.1, ss.131-141, 1996 (SCI-Expanded, Scopus)

193. Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma

DEMİRER T., Buckner C., Gooley T., Appelbaum F., Rowley S., Chauncey T., et al.
Bone Marrow Transplantation , cilt.17, sa.6, ss.937-941, 1996 (SCI-Expanded, Scopus)

194. Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease

Schiffman K., Bensinger W., Appelbaum F., Rowley S., Lilleby K., Clift R., et al.
Bone Marrow Transplantation , cilt.17, sa.6, ss.943-950, 1996 (SCI-Expanded, Scopus)

195. High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer

DEMİRER T., Buckner C., Appelbaum F., Clift R., Storb R., Myerson D., et al.
Bone Marrow Transplantation , cilt.17, sa.5, ss.769-774, 1996 (SCI-Expanded, Scopus)

196. Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: Phase I dose escalation of busulfan based on targeted plasma levels

DEMİRER T., Buckner C., Appelbaum F., Bensinger W., Sanders J., Lambert K., et al.
Bone Marrow Transplantation , cilt.17, sa.4, ss.491-495, 1996 (SCI-Expanded, Scopus)

197. Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: Phase I dose escalation of busulfan based on targeted plasma levels

DEMİRER T., Buckner C., Appelbaum F., Lambert K., Bensinger W., Clift R., et al.
Bone Marrow Transplantation , cilt.17, sa.3, ss.341-346, 1996 (SCI-Expanded, Scopus)

198. Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy

Bensinger W., Buckner C., Rowley S., DEMİRER T., Storb R., Appelbaum F., et al.
Bone Marrow Transplantation , cilt.17, sa.SUPPL. 2, 1996 (Scopus)

199. Optimization of peripheral flood stem cell mobilization

Demirer T., Buckner C., Bensinger W.
STEM CELLS , cilt.14, sa.1, ss.106-116, 1996 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

200. Transplantation of allogeneic peripheral blood stem cells.

Bensinger W., Buckner C., DEMİRER T., Storb R., Appelbaum F.
Bone marrow transplantation , cilt.17 Suppl 2, 1996 (Scopus)

201. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor

Bensinger W., Clift R., Anasetti C., Appelbaum F., Demirer T., Rowley S., et al.
STEM CELLS , cilt.14, sa.1, ss.90-105, 1996 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

202. High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma

Bensinger W., Rowley S., Demirer T., Lilleby K., Schiffman K., Clift R., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.14, sa.5, ss.1447-1456, 1996 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

203. Autologous stem cell transplantation for patients with multiple myeloma

Demirer T., Bensinger W., Appelbaum F., Rowley S., Buckner C.
BLOOD , cilt.86, sa.10, ss.815, 1995 (SCI-Expanded, Scopus)

204. Comparison of granulocyte-colony stimulating factor (rhG-CSF) mobilized peripheral blood stem cells (PBSC) and bone marrow for autologous transplantation in patients with acute myelogenous leukemia (AML)

Demirer T., Bensinger W., Rowley S., Appelbaum F., Petersen F., Chauncey T., et al.
BLOOD , cilt.86, sa.10, ss.381, 1995 (SCI-Expanded, Scopus)

205. Quantitative CD34 collection does not independently predict clinical outcome after autologous PBSC transplantation (APBSCT)

Chauncey T., Gooley T., Appelbaum F., Demirer T., Holmberg L., Lilleby K., et al.
BLOOD , cilt.86, sa.10, ss.3751, 1995 (SCI-Expanded, Scopus)

206. ALLOGENEIC MARROW TRANSPLANTATION FOLLOWING CYCLOPHOSPHAMIDE AND ESCALATING DOSES OF HYPERFRACTIONATED TOTAL-BODY IRRADIATION IN PATIENTS WITH ADVANCED LYMPHOID MALIGNANCIES - A PHASE I/II TRIAL

DEMIRER T., PETERSEN F., APPELBAUM F., BARNETT T., SANDERS J., DEEG H., et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.32, sa.4, ss.1103-1109, 1995 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

207. RAPID ENGRAFTMENT AFTER AUTOLOGOUS TRANSPLANTATION UTILIZING MARROW AND RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA

DEMİRER T., BUCKNER C., APPELBAUM F., PETERSEN F., ROWLEY S., WEAVER C., et al.
BONE MARROW TRANSPLANTATION , cilt.15, sa.6, ss.915-922, 1995 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

208. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor

Bensinger W., Weaver C., Appelbaum F., Rowley S., DEMİRER T., Sanders J., et al.
Blood , cilt.85, sa.6, ss.1655-1658, 1995 (Scopus)

209. PERIPHERAL-BLOOD STEM-CELL COLLECTIONS AFTER PACLITAXEL, CYCLOPHOSPHAMIDE, AND RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH BREAST AND OVARIAN-CANCER

DEMIRER T., ROWLEY S., BUCKNER C., APPELBAUM F., LILLEBY K., STORB R., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.13, sa.7, ss.1714-1719, 1995 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

210. FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS

BENSINGER W., APPELBAUM F., ROWLEY S., STORB R., SANDERS J., LILLEBY K., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.13, sa.10, ss.2547-2555, 1995 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

211. Optimization of peripheral blood stem cell collection.

DEMİRER T., Bensinger W.
Current opinion in hematology , cilt.2, sa.3, ss.219-226, 1995 (Scopus)

212. Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation

DEMİRER T., Gooley T., Buckner C., Petersen F., Lilleby K., Rowley S., et al.
Bone Marrow Transplantation , cilt.15, sa.6, ss.907-913, 1995 (SCI-Expanded, Scopus)

213. HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAD RECEIVED PRIOR DOSE-LIMITING RADIATION-THERAPY

DEMIRER T., WEAVER C., BUCKNER C., PETERSEN F., BENSINGER W., SANDERS J., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.13, sa.3, ss.596-602, 1995 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

214. Fatal bone marrow necrosis following fludarabine administration in a patient with indolent lymphoma

Aboulafia D. M., DEMİRER T.
Leukemia and Lymphoma , cilt.19, sa.1-2, ss.181-184, 1995 (SCI-Expanded, Scopus)

215. Transplantation of allogeneic peripheral blood stem cells

Bensinger W. I., Appelbaum F. A., DEMİRER T., Torok‐Storb B., Storb R., Buckner C. D.
STEM CELLS , cilt.13, sa.3 S, ss.63-70, 1995 (Scopus)

216. FLOW CYTOMETRIC MEASUREMENT OF PROLIFERATION-ASSOCIATED NUCLEAR ANTIGEN P105 AND DNA CONTENT IN IMMUNO-PROLIFERATIVE SMALL-INTESTINAL DISEASE (IPSID)

DEMIRER T., UZUNALIMOGLU O., ANDERSON T., KOETHE S., MCFADDEN P., DEMIRER S., et al.
JOURNAL OF SURGICAL ONCOLOGY , cilt.58, sa.1, ss.25-30, 1995 (SCI-Expanded)

217. RAPID ENGRAFTMENT AFTER AUTOLOGOUS TRANSPLANTATION UTILIZING MARROW AND RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR MOBILIZED PERIPHERAL-BLOOD STEM-CELLS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA

DEMİRER T., BUCKNER C., APPELBAUM F., PETERSEN F., ROWLEY S., LILLEBY K., et al.
BLOOD , cilt.84, sa.10, 1994 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

218. THE INFLUENCE OF TOTAL NUCLEATED CELL DOSE FROM MARROW HARVESTS ON OUTCOME IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA UNDERGOING AUTOLOGOUS TRANSPLANTATION

DEMIRER T., GOOLEY T., BUCKNER C., PETERSEN F., LILLEBY K., ROWLEY S., et al.
BLOOD , cilt.84, sa.10, 1994 (SCI-Expanded, Scopus)

219. 4 VARIED CASES OF INTRAVASCULAR LYMPHOMATOSIS AND A LITERATURE-REVIEW

DEMİRER T., DAIL D., ABOULAFIA D.
CANCER , cilt.73, sa.6, ss.1738-1745, 1994 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

220. Myasthenic (Eaton-Lambert) syndrome associated with pulmonary large-cell neuroendocrine carcinoma

DEMİRER T., Ravits J., Aboulafia D.
Southern Medical Journal , cilt.87, sa.11, ss.1186-1189, 1994 (SCI-Expanded, Scopus)

221. Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed disease

DEMİRER T., Buckner C. D., Lilleby K., Weaver C., Longin K., Appelbaum F. R., et al.
Cancer , cilt.74, sa.2, ss.715-721, 1994 (Scopus)

222. INTRATUMOR HETEROGENEITY OF DNA-PLOIDY AND CORRELATIONS WITH CLINICAL STAGE AND HISTOLOGIC GRADE IN PROSTATE-CANCER

KUCUK O., DEMIRER T., GILMANSACHS A., TAW I., MANGOLD M., SINGH S., et al.
JOURNAL OF SURGICAL ONCOLOGY , cilt.54, sa.3, ss.171-174, 1993 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

223. DIET AND STOMACH-CANCER INCIDENCE - A CASE CONTROL STUDY IN TURKEY

DEMIRER T., ICLI F., UZUNALIMOGLU O., KUCUK O.
CANCER , cilt.65, sa.10, ss.2344-2348, 1990 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 273

1. EASIX OUTPERFORMS EBMT AND CIBMTR RISK MODELS IN PREDICTING VOD/SOS DESPITE DEFIBROTIDE USE IN ALLOGENEIC HSCT

Bektas M., Gungor A., ŞAHİN U., Yuksel M. K., TOPRAK S. K., TOPÇUOĞLU P., et al.
52nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), ELECTR NETWORK, 22 - 25 Mart 2026, cilt.61, ss.304-305, (Özet Bildiri)

2. IMPACT OF HLA B LEADER GENOTYPE ON SINGLE HLA MISMATCHED ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTICENTER COHORT STUDY

Yucel E. E., Acar C., Mersin S., Kayikci O., Olgun A., Yurttas N. O., et al.
52nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), ELECTR NETWORK, 22 - 25 Mart 2026, cilt.61, ss.334-336, (Özet Bildiri)

3. SAÇLI HÜCRELİ LÖSEMİDE KLADRİBİN MONOTERAPİSİNİN UZUN DÖNEM SONUÇLARI VE NÜKSÜ ÖNGÖREN İMMÜNOFENOTİPİK BELİRTEÇLER

BEKTAŞ M., YURDAKUL B. E., DALVA K., ŞAHİN U., CENGİZ SEVAL G., TOPRAK S. K., et al.
51.Ulusal Hematoloji kongresi, Türkiye, 28 Ekim - 02 Kasım 2025, (Tam Metin Bildiri)

4. YOĞUN İNDÜKSİYONA UYGUN AKUT MİYELOİD LÖSEMİ HASTALARINDA HİPOMETİLE EDİCİ İLAÇ-VENETOKLAKS İLE İNDÜKSİYON TEDAVİSİNİN SONUÇLARI

ÇALIŞ U., ŞAHİN U., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
51.Ulusal Hematoloji kongresi, Türkiye, 28 Ekim 2025, (Tam Metin Bildiri)

5. NÜKS/DİRENÇLİ AKUT MYELOİD LÖSEMİ TEDAVİSİNDE FLAG-İDA İLE KOMBİNE VENETOKLAKS KULLANIMI: TEK MERKEZ DENEYİMİ

KÖKCÜ G., DALVA K., HANEDAR E., SÖNMEZ G. M., BEKTAŞ M., YÜKSEL M., et al.
51.Ulusal Hematoloji kongresi, Türkiye, 28 Ekim - 02 Kasım 2025, (Tam Metin Bildiri)

6. WHO VE ICC IŞIĞINDA MPN’LERİN GENETİK ÖZELLİKLERİ VE KLİNİK KORELASYONU

SÖNMEZ G. M., LEBLEBİCİ C. B., YÜRÜR KUTLAY N., CENGİZ SEVAL G., TOPRAK S. K., TOPÇUOĞLU P., et al.
51.Ulusal Hematoloji kongresi, Türkiye, 28 Ekim - 02 Kasım 2025, (Tam Metin Bildiri)

7. İNFÜZE EDİLEN CD34+ VE CD3+ HÜCRE MİKTARININ VE CD34+/CD3+ ORANININ AKHN SONUÇLARINA ETKİLERİ

ŞEN T., KILIÇ Ö., ŞAHİN U., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., et al.
51.Ulusal Hematoloji kongresi, Türkiye, 28 Ekim - 02 Kasım 2025, (Tam Metin Bildiri)

8. ATG KULLANILAN ALLOJENİK KÖK HÜCRE NAKLİNDE DAHA YÜKSEK TRASPLANTASYON ÖNCESİ LENFOSİT SAYISI SAĞKALIM ORANININ İYİLEŞMESİYLE İLİŞKİLİDİR

KÖKCÜ G., DALVA K., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
51.Ulusal Hematoloji kongresi, Türkiye, 28 Ekim - 02 Kasım 2025, (Tam Metin Bildiri)

9. NÜKS/DİRENÇLİ AKUT MYELOİD LÖSEMİ TEDAVİSİNDE FLAG-İDA İLE KOMBİNE VENETOKLAKS KULLANIMI: TEK MERKEZ DENEYİMİ

KÖKCÜ G., DALVA K., HANEDAR E., İŞİKAN H. E., SÖNMEZ G. M., BEKTAŞ M., et al.
51.Ulusal Hematoloji kongresi, Türkiye, 28 Ekim 2025, (Tam Metin Bildiri)

10. SPİNAL MANYETİK REZONANS GÖRÜLTÜLEMEDE ANORMAL KEMİK İLİĞİ YOĞUNLUĞUNUN HEMATOLOJİK HASTALIKLARLA İLİŞKİSİ

AYDOĞAN M., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
51.Ulusal Hematoloji kongresi, Türkiye, 28 Ekim - 02 Kasım 2025, (Tam Metin Bildiri)

11. NEGATIVE IMPACT OF HIGH SERUM CREATININE AND LACTATE DEHYDROGENASE AT DIAGNOSIS CAN BE OVERCOME BY AUTOLOGOUS STEM CELL TRANSPLANTATION

Yucedag M. D., BULUT S., Yucedag T. K., Akbay P. M., TOPRAK S. K., YÜKSEL M., et al.
6th European-Myeloma-Network Meeting, Athens, Yunanistan, 10 - 12 Nisan 2025, cilt.110, ss.39, (Özet Bildiri)

12. REAL-LIFE DATA ON SAFETY AND EFFICACY OF AUTOLOGOUS STEM CELL TRANSPLATATION IN ELDERLY PATIENTS WITH MULTIPLE MYELOMA

BULUT S., Yucedag D., Akbay P., Yucedag K., TOPRAK S. K., YÜKSEL M., et al.
6th European-Myeloma-Network Meeting, Athens, Yunanistan, 10 - 12 Nisan 2025, cilt.110, ss.57, (Özet Bildiri)

13. PERİFERİK T HÜCRELİ LENFOMA TANILI HASTALARIN ANALİZİ: TEK MERKEZ DENEYİMİ

Yüksel M., Cengiz Seval G., Topçuoğlu P., Arslan Ö., Özcan M., Demirer T.
50.Ulusal Hematoloji Kongresi, Antalya, Türkiye, 29 Ekim - 02 Kasım 2024, ss.136-137, (Tam Metin Bildiri)

14. MİKOSİZ FUNGOİDES VE SEZARY SENDROMLU HASTALARDA BRENTUXİMAB VEDOTİN TEDAVİSİNİN UZUN DÖNEM SONUÇLARI

Yüksel M., Şanlı H., Dalva K., Cengiz Seval G., Topçuoğlu P., Arslan Ö., et al.
50.Ulusal Hematoloji Kongresi, Antalya, Türkiye, 29 Ekim - 02 Kasım 2024, ss.111, (Tam Metin Bildiri)

15. PAROKSİSMAL NOKTURNAL HEMOGLOBİNÜRİ TANILI HASTALARIN DEĞERLENDİRMESİ, TEK MERKEZLİ ÇALIŞMA

BEKTAŞ M., ÇİFTÇİ A., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., ÖZCAN M., et al.
50.Ulusal Hematoloji Kongresi, 29 Ekim - 02 Kasım 2024, (Tam Metin Bildiri)

16. MANTLE HÜCRELİ LENFOMA TANILI HASTALARDA İBRUTİNİB KULLANIMI: TEK MERKEZ DENEYİMİ

KÖKCÜ G., CENGİZ SEVAL G., YÜKSEL M., TOPRAK S. K., ARSLAN Ö., ÖZCAN M., et al.
50.Ulusal Hematoloji Kongresi, 29 Ekim - 02 Kasım 2024, (Tam Metin Bildiri)

17. NÜKS DİRENÇLİ T HÜCRELİ LENFOMALARDA PRALATREKSAT KULLANIMI: TEK MERKEZ DENEYİMİ

SÖNMEZ G. M., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
50.Ulusal Hematoloji Kongresi, 29 Ekim - 02 Kasım 2024, (Tam Metin Bildiri) Creative Commons License

18. STEROİD REFRAKTER GRAFT VERSUS HOST HASTALIĞINDA FOTOFEREZ KULLANIMI VE YANITLARININ DEĞERLENDİRİLMESİ, TEK MERKEZ DENEYİMİ

BEKTAŞ M., ÇİFTÇİ A., CENGİZ SEVAL G., TOPRAK S. K., TOPÇUOĞLU P., ÖZCAN M., et al.
50.Ulusal Hematoloji Kongresi, 29 Ekim - 02 Kasım 2024, (Tam Metin Bildiri) Creative Commons License

19. HİPEREOZİNOFİLİK SENDROM ALT TİPLERİNDE TANI VE TEDAVİ: RETROSPEKTİF TEK MERKEZLİ ÇALIŞMA

BEKTAŞ M., ÇİFTÇİ A., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ÖZCAN M., et al.
50.Ulusal Hematoloji Kongresi, 29 Ekim - 02 Kasım 2024, (Tam Metin Bildiri)

20. GÜNCEL KLAVUZLAR EŞLİĞİNDE KLİNİKTE MASTOSİTOZ: TEK MERKEZ DENEYİMİ

AYDOĞAN M., CENGİZ SEVAL G., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
50.Ulusal Hematoloji Kongresi, 29 Ekim - 02 Kasım 2024, (Tam Metin Bildiri)

21. MİKOSİZ FUNGOİDES VE SEZARY SENDROMLU HASTALARDA BRENTUXİMAB VEDOTİN TEDAVİSİNİN UZUN DÖNEM SONUÇLARI

SÖNMEZ G. M., ÖZSAN İ., DÜZ B., ŞANLI H., CENGİZ SEVAL G., DALVA K., et al.
50.Ulusal Hematoloji Kongresi, 29 Ekim - 02 Kasım 2024, (Tam Metin Bildiri)

22. Prognostic evaluation of PET/CT in residual post-chemotherapy +/- RT masses in patients with Hodgkin Lymphoma and its impact on survival

BEKTAŞ M., KAR İ., CENGİZ SEVAL G., TOPRAK S. K., TOPÇUOĞLU P., ÖZCAN M., et al.
11TH AEGEAN HEMATOLOGY ONCOLOGY SYMPOSIUM, 19 - 22 Eylül 2024, (Tam Metin Bildiri)

23. Allogeneic Stem Cell Transplantation for Relapsed and/or Refractory Hodgkin Lymphoma: A Multicenter Real World Experience

Koyun D., ŞAHİN U., CENGİZ SEVAL G., Sahin D. G., Gokmen A., Bozdag S. C., et al.
65th Annual Meeting of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 9 - 12 Aralık 2023, cilt.142, (Özet Bildiri)

24. ALPHA-1-ANTITRYPSIN EXPERIENCE FOR STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE

Koyun D., Cengiz Seval G., Bozdag S. C., Toprak S. K., Topçuoğlu P., Özcan M., et al.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 Nisan 2023, ss.301-302, (Özet Bildiri)

25. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPS/REFRACTORY LYMPHOMA PATIENTS: A SINGLE CENTER EXPERIENCE

Karakaya B., Yilmaz H., Ermis G. Y., Cengiz Seval G., Bozdag S. C., Toprak S. K., et al.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 - 26 Nisan 2023, ss.457-458, (Özet Bildiri)

26. EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES

Beksaç M., Cengiz Seval G., Civriz Bozdağ S., Toprak S. K., Yüksel M., Topçuoğlu P., et al.
The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians, Paris, Fransa, 23 Nisan 2023, cilt.58, ss.107, (Tam Metin Bildiri)

27. P19 EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES

BEKSAÇ M., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation, Fransa, 23 Nisan 2023, (Tam Metin Bildiri)

28. The Impact of CD34+Cell and Immunefector Cell Dose on Transplant Outcomes

Koyun D., Cengiz Seval G., Bozdag S. C., Toprak S. K., Topçuoğlu P., Özcan M., et al.
64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, Amerika Birleşik Devletleri, 10 - 13 Aralık 2022, cilt.140, ss.12673-12674, (Özet Bildiri) Creative Commons License

29. Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia: A single center experience

İLHAN ., Yavuz G., CENGİZ SEVAL G., Bozdag S. C., YÜKSEL M., TOPÇUOĞLU P., et al.
48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Çek Cumhuriyeti, 19 - 23 Mart 2022, cilt.57, ss.125, (Özet Bildiri)

30. The efficacy and safety of second allogeneic hematopoietic stem cell transplantation

TOPRAK S. K., KIRCALİ E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
2022 ASCO Annual Meeting, Amerika Birleşik Devletleri, 01 Haziran 2022, (Tam Metin Bildiri)

31. Prophylactic defibrotide is effective for acute graft versus host disease as well as sinusoidal obstructive syndrome

KIRCALİ E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), Amerika Birleşik Devletleri, 19 - 22 Mart 2022, (Tam Metin Bildiri)

32. Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia: A single center experience

İLHAN O., YAVUZ G., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Amerika Birleşik Devletleri, 19 - 22 Mart 2022, (Tam Metin Bildiri)

33. İKİNCİ ALLOJENEİK KÖK HÜCRE NAKLİ: GERÇEK YAŞAM VERİSİ

KIRCALI E., CENGİZ SEVAL G., ÖZTÜRK C., YILMAZ H., Yavuz G., Karakaya B., et al.
14. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 10 Mart 2022, (Tam Metin Bildiri)

34. GRAFT VERSUS HOST HASTALIĞI PROFİLAKSİSİNDE ATG VE POST CY KULLANIMININ NAKİL SONUÇLARINA ETKİSİ: TEK MERKEZ DENEYİMİ

Karakaya B., ŞAHİN Y. İ., MAMMADLI H., Yavuz G., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., et al.
14. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 10 Mart 2022, (Tam Metin Bildiri)

35. THE OUTCOME OF AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKIN LYPHOMA

İLHAN O., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
63TH ASH CONGRESS, ATLANTA, Amerika Birleşik Devletleri, 8 - 11 Aralık 2021, (Tam Metin Bildiri)

36. The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma

İLHAN O., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
63rd ASH Annual Meeting and Exposition, 11 Aralık 2021, (Tam Metin Bildiri)

37. T/B LENFOBLASTİK LENFOMA TANILI HASTALARIN YENİ TEDAVİLER IŞIĞINDA RETROSPEKTİF DEĞERLENDİRİLMESİ

Karakaya B., Akbulut H., Öztürk C., Koyun D., Kırcalı E., Yilmaz H., et al.
47. Ulusal Hematoloji Kongresi , Antalya, Türkiye, 4 - 07 Kasım 2021, ss.178-179, (Tam Metin Bildiri)

38. AKUT PROMİYELOSİTİK LÖSEMİ TANILI HASTALARIN KLİNİK ÖZELLİKLERİ VE TEDAVİ SONUÇLARI: TEK MERKEZ DENEYİMİ

Yavuz Ermiş G., Yilmaz H., Özütemiz S., Selvi N., Öztürk C., Kırcalı E., et al.
47. Ulusal Hematoloji Kongresi , Antalya, Türkiye, 4 - 07 Kasım 2021, ss.202-204, (Tam Metin Bildiri)

39. HODGKİN LENFOMA TANILI HASTALARDA EKSTRANODAL TUTULUM VE YENİ TEDAVİLER

Yavuz Ermiş G., Yilmaz H., Özütemiz S., Selvi N., Öztürk C., Kırcalı E., et al.
47. Ulusal Hematoloji Kongresi , Antalya, Türkiye, 4 - 07 Kasım 2021, ss.346-347, (Tam Metin Bildiri)

40. PROFLAKTİK DEFİBROTİD SOS DIŞINDA AKUT GRAFT VS HOST HASTALIĞINDA DA ETKİN

KIRCALI E., CENGİZ SEVAL G., ÖZTÜRK C., YILMAZ H., Yavuz G., Karakaya B., et al.
47. Ulusal Hematoloji Kongresi, 04 Kasım 2021, (Tam Metin Bildiri)

41. RELAPS/ REFRAKTER HODGKİN LENFOMA HASTALARINDA ALLOJENİK HEMATOPOETİK KÖK HÜCRE NAKLİ: TEK MERKEZ DENEYİMİ

Koyun D., Şahin U., Cengiz Seval G., Civriz Bozdağ S., Toprak S. K., Yüksel M., et al.
13. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 2 - 03 Nisan 2021, sa.52, ss.104-105, (Tam Metin Bildiri)

42. Relaps/Refrakter Hodgkin Lenfoma Hastalarında Allojenik Hematopoetik Kök Hücre Nakli: Tek Merkez Deneyimi

KOYUN D., ŞAHİN U., SEVAL G. C., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M. K., et al.
13. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 2 - 03 Nisan 2021, (Tam Metin Bildiri)

43. Allojenik Kök Hücre Nakli Hastalarında Peritransplant Metronidazol Kullanımıyla Akut GVHD Riskinin İlişkisi

KIRCALİ E., SEVAL G. C., Öztürk C., CİVRİZ BOZDAĞ S., YÜKSEL M. K., TOPÇUOĞLU P., et al.
13. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 2 - 03 Nisan 2021, (Tam Metin Bildiri)

44. MULTİPL MİYELOMDA OTOLOG PRİFERİK KÖK HÜCRE NAKLİ SONRASI ERKEN NÜKSÜ BELİRLEMEDE CIBMTR, ISS VE R-ISS SKORLAMA SİSTEMLERİNİN KARŞILAŞTIRILMASI

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
13. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 02 Nisan 2021, (Tam Metin Bildiri)

45. Solid Organ Nakli Ve Allojenik Kök Hücre Nakli Sonrası Gelişen Post-Transplant Lenfoproliferatif Hastalık- Tek Merkez Deneyimi

Öztürk C., KIRCALİ E., KOYUN D., YILMAZ H., YAVUZ G., KARAKAYA B., et al.
13. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 2 - 03 Nisan 2021, (Tam Metin Bildiri)

46. ALLOJENİK KÖK HÜCRE NAKLİ HASTALARINDA PERİTRANSPLANT METRONİDAZOL KULLANIMIYLA AKUT GVHD RİSKİNİN İLİŞKİ

KIRCALI E., CENGİZ SEVAL G., ÖZTÜRK C., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
13. Ulusal kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 02 Nisan 2021, (Tam Metin Bildiri)

47. THE IMPACT OF PRETRANSPLANT IMMUNOMODULATORY DRUGS ON CMV REACTIVATION

YÜKSEL M., CENGİZ SEVAL G., USLU A., KIRCALI E., KOYUN D., Yavuz G., et al.
8 45 th International Congress on Leukemia Lymphoma Myeloma, Ankara, Türkiye, 21 Mayıs 2021, cilt.38, sa.71, ss.1-81, (Tam Metin Bildiri)

48. The impact of pretransplant ımmunomodulatory drugs on cmv reactıvatıon

YÜKSEL M., CENGİZ SEVAL G., USLU A., KIRCALI E., KOYUN D., YAVUZ G., et al.
8th International congress on leukemia lymphoma myeloma, 2021, 21 Mayıs 2021, (Tam Metin Bildiri)

49. Impact of Peritransplant Metronidazole Use on Acute Graft Versus Host Disease in Allogeneic Hematopoietic Transplant Patients

KIRCALİ E., SEVAL G. C., ÖZTÜRK C., BOZDAĞ S., YÜKSEL M. K., TOPÇUOĞLU P., et al.
Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, 8 - 12 Şubat 2021, (Tam Metin Bildiri)

50. Comparative Analysis and Validation of CIBMTR Early Relapse Risk Score with ISS and R-ISS: Single Center Experience from Ankara University

SEVAL G. C., BOZDAĞ S., TOPRAK S. K., YÜKSEL M. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, 08 Şubat 2021, (Tam Metin Bildiri)

51. GRAFT VS HOST HASTALIĞINDA ALFA- 1 ANTİTRİPSİN DENEYİMİMİZ

Koyun D., Cengiz Seval G., Kırcalı E., Civriz Bozdağ S., Toprak S. K., Topçuoğlu P., et al.
46. Ulusal Hematoloji Kongresi , Antalya, Türkiye, 28 - 31 Ekim 2020, sa.283, ss.117-118, (Tam Metin Bildiri)

52. FOLİKÜLER LENFOMADA BAZAL PET’ TE TOPLAM METABOLİK TÜMÖR HACMİ VE TOPLAM LEZYON GLİKOLİZİNİN PROGNOSTİK ÖNEMİ

Kırcalı E., Cengiz Seval G., Araz M., Uslu A., Öztürk C., Koyun D., et al.
46. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 28 - 31 Ekim 2020, sa.278, ss.105, (Tam Metin Bildiri)

53. AKUT MYELOBLASTİK LÖSEMİ HASTALARINDA NÜKLEOFOSMİN MUTASYONU MİNİMAL REZİDÜEL HASTALIK TAKİBİNDE YOL GÖSTERİCİMİDİR

CENGİZ SEVAL G., ÖZCAN M., TOPÇUOĞLU P., DEMİRER T., BEKSAÇ M., CİVRİZ BOZDAĞ S., et al.
42.Ulusal Hematoloji Kongresi, Türkiye, 28 - 30 Ekim 2020, (Tam Metin Bildiri)

54. Foliküler lenfomada bazal PET'te toplam metabolik tümör hacmi ve toplan lezyon glikolizinin prognostik önemi.

CENGİZ SEVAL G., ÖZCAN M., TOPÇUOĞLU P., DEMİRER T., BEKSAÇ M., ÖZKAN E., et al.
46. Ulusal Hematoloji Kongresi, Türkiye, 28 - 31 Ekim 2020, (Tam Metin Bildiri)

55. Role Of Chımerısm And Flow-Cytometrıc Monıtorıng Of Measurable Resıdualdısease (Mrd) After Allogeneıc Hematopoıetıc Stem Cell Transplantatıon (Allohsct) In Predıctıng Relapse In Acute Myeloıd Leukemıa (AML)

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., DALVA K., et al.
46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT, 29 Ağustos - 01 Eylül 2020, (Tam Metin Bildiri)

56. The Influence Of Antı-Thymocyte Globulın (Atg) On The Outcomes Of Patıents Wıth Aml W/Wo Measurable Resıdual Dısease (Mrd) At The Tıme Of Unrelated Donor Transplantatıon

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., KIRCALİ E., BALTACI M. A., TOPÇUOĞLU P., et al.
46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 29 Ağustos - 01 Eylül 2020, (Tam Metin Bildiri)

57. Flamsa-Based Hıgh-Dose Sequentıal Condıtıonıng Regımen Followed By Allogeneıc Hematopoıetıc Stem Cell Transplantatıon (Allo-Hsct): Is It Effectıveın Patıents Wıth Prımary Refractory Or Relapsed Acute Leukemıa?

CENGİZ SEVAL G., EKİN K., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.
46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 29 Ağustos - 01 Eylül 2020, (Tam Metin Bildiri)

58. Treatment Of Thrombocytopenıa After Allogeneıc Stem Cell Transplantatıonwıth Eltrombopag

KIRCALİ E., CENGİZ SEVAL G., KOYUN D., ÖZTÜRK C., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 29 Ağustos - 01 Eylül 2020, (Tam Metin Bildiri)

59. Allogeneic hematopoietic stem cell transplantation for primary myelofibrosis: A single-center experience.

Demirer T., Seval G. C., Bozdag S. C., Toprak S. K., Yuksel M. K., Topcuoglu P., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 - 31 Mayıs 2020, cilt.38, (Özet Bildiri)

60. HEMORAJİK SİSTİT İÇİN YARGILANAN SİKLOFOSFAMİD SUÇSUZ BULUNDU: TEK MERKEZ 7 YILLIK DENEYİM

CENGİZ SEVAL G., ÖZCAN M., TOPÇUOĞLU P., DEMİRER T., BEKSAÇ M., CİVRİZ BOZDAĞ S., et al.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 5 - 07 Mart 2020, (Tam Metin Bildiri)

61. CD34 VE İMMUNEFEKTÖR HÜCRE SAYIMININ TRANSPLANTASYON SONUÇLARINA ETKİSİ

CENGİZ SEVAL G., ÖZCAN M., TOPÇUOĞLU P., DEMİRER T., BEKSAÇ M., CİVRİZ BOZDAĞ S., et al.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 5 - 07 Mart 2020, (Tam Metin Bildiri)

62. AML TANISI İLE AKRABA DIŞI VERİCİDEN AHKHN YAPILAN HASTALARDA ATG KULLANIMININ NAKİL SONUÇLARINA ETKİSİ

CENGİZ SEVAL G., ÖZCAN M., TOPÇUOĞLU P., DEMİRER T., BEKSAÇ M., CİVRİZ BOZDAĞ S., et al.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 5 - 07 Mart 2020, (Tam Metin Bildiri)

63. CD34+ VE İMMUNEFEKTÖR HÜCRE SAYIMININ TRANSPLANTASYON SONUÇLARINA ETKİSİ

Koyun D., Cengiz Seval G., Dalva K., Uslu A., Öztürk C., Kırcalı E., et al.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Muğla, Türkiye, 5 - 07 Mart 2020, sa.159, ss.60-61, (Tam Metin Bildiri)

64. Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

CENGİZ SEVAL G., ÖZTÜRK N., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR 2020, 19 - 23 Şubat 2020, (Tam Metin Bildiri)

65. Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow

CENGİZ SEVAL G., USLU A., KIRCALİ E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR, 19 - 23 Şubat 2020, (Tam Metin Bildiri)

66. Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

SEVAL G. C., Öztürk n., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
61st ASH Annual Meeting, 7 - 10 Aralık 2019, (Tam Metin Bildiri)

67. Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

CENGİZ SEVAL G., Uslu A., Kircali E., CİVRİZ BOZDAĞ S., DALVA K., TOPRAK S. K., et al.
61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 7 - 10 Aralık 2019, cilt.134, (Özet Bildiri)

68. Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?

Kircali E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., Yuksel M. K., ARSLAN Ö., et al.
61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 7 - 10 Aralık 2019, cilt.134, (Özet Bildiri)

69. Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

CENGİZ SEVAL G., Ozturk N., CİVRİZ BOZDAĞ S., Yuksel M. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 7 - 10 Aralık 2019, cilt.134, (Özet Bildiri)

70. HANGİSİ, ORJİNAL İMATİNİB Mİ JENERİK Mİ KRONİK MYELOİD LÖSEMİDE DAHA ETKİN?

KIRCALI E., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.
45. Ulusal Hematoloji Kongresi, 31 Ekim 2019, (Tam Metin Bildiri)

71. YENİ TANI KLL HASTALARINDA TANI SIRASINDAKİ CD49DEKSPRESYONUNUN HASTALIĞA OZGU BAŞKA PARAMETRELERLEİLİŞKİSİ

TOPRAK S. K., güven m., CENGİZ SEVAL G., DALVA K., İpek Ş., Okul N., et al.
45. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 30 Ekim - 02 Kasım 2019, (Özet Bildiri)

72. KRONİK MİYELOİD LOSEMİ (KML) HASTALARINDA KML KOKHUCRESİ BCR- ABL’DEN BAĞIMSIZ PROGNOSTİK BİR FAKTOR OLABİLİR Mİ?

TOPRAK S. K., güven m., CENGİZ SEVAL G., DALVA K., İpek Ş., Okul N., et al.
45. ULUSAL HEMATOLOJİ KONGRESİ, Türkiye, 30 Ekim - 02 Kasım 2019, (Özet Bildiri)

73. Splenic marginal zone lymphoma: Clinical characteristics and prognostic factors in a series of 52 patients

CENGİZ SEVAL G., Topcuoglu P., Arslan O., GÜRMAN G., Demirer T., Kuzu I., et al.
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30, ss.441, (Özet Bildiri) Sürdürülebilir Kalkınma

74. Negative Impact of High LDH at Diagnosis on OS, But Not PFS, Can Be Overcome by Autologous Stem Cell Transplantation

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
17th International Myeloma Workshop, 12 - 15 Eylül 2019, (Tam Metin Bildiri)

75. Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT?

YÜKSEL M., CENGİZ SEVAL G., Uslu A., Kircili E., KOYUN D., Ozturk C., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.505-506, (Özet Bildiri)

76. Haploidentical stem cell transplantation may be an option for hematological malignancies in urgent conditions

İLHAN O., CENGİZ SEVAL G., Uslu A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.382, (Özet Bildiri)

77. Is mobilization with chemotherapy effect response in the multiple myeloma?

CENGİZ SEVAL G., Uslu A., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., ÖZCAN M., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.500, (Özet Bildiri)

78. Can Nelarabıne Rescue The Graft After Allogeneıc Hematopoıetıc Stem Cell Transplantatıon In T-All ?

YÜKSEL M., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
24 Congress of the European Hematology Association, 13 - 16 Haziran 2019, (Özet Bildiri)

79. LEUKAPHERESIS REDUCES 4-WEEK MORTALITY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH HYPERLEUKOCYTOSIS - A RETROSPECTIVE STUDY FROM A TERTIARY CENTER

Cengiz Seval G., Uslu A., Civriz Bozdağ S., Toprak S. K., Yüksel M., Topçuoğlu P., et al.
7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Türkiye, 2 - 04 Mayıs 2019, ss.37, (Tam Metin Bildiri)

80. CAN THE DRUGS USED BEFORE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (ASCT) HAVE IMPACT ON CMV REACTIVATION THAT RESULTS IN DECREASED OS IN MYELOMA PATIENTS AFTER ASCT?

Yüksel M., Cengiz Seval G., Uslu A., Kırcalı E., Koyun D., Öztürk C., et al.
7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Türkiye, 2 - 04 Mayıs 2019, ss.59, (Tam Metin Bildiri)

81. HAPLOIDENTICAL STEM CELL TRANSPLANTATION MAY BE A GOOD ALTERNATIVE AS SALVAGE TREATMENT FOR HEAVILY PRETREATED PATIENTS WITH LEUKEMIA

Cengiz Seval G., Uslu A., Civriz Bozdağ S., Toprak S. K., Yüksel M., Topçuoğlu P., et al.
7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Türkiye, 2 - 04 Mayıs 2019, ss.56-57, (Tam Metin Bildiri)

82. IS AGE AN IMPORTANT FACTOR FOR AUTOLOGOUS PERIPHERAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ELDERLY PATIENTS WITH NONHODGKIN LYMPHOMA?

Cengiz Seval G., Uslu A., Civriz Bozdağ S., Toprak S. K., Yüksel M., Topçuoğlu P., et al.
7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Türkiye, 2 - 04 Mayıs 2019, ss.47-48, (Tam Metin Bildiri)

83. SUCCESSFUL TREATMENT OF GRAFT FAILURE WITH SECOND ALLOGENEIC STEM CELL TRANSPLANTATION WITHOUT CONDITIONING REGIMEN

Cengiz Seval G., Uslu A., Öztürk C., Civriz Bozdağ S., Yüksel M., Topçuoğlu P., et al.
8th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Türkiye, 2 - 04 Mayıs 2019, ss.75, (Tam Metin Bildiri)

84. CAN AUTOLOGOUS STEM CELL TRANSPLANTATION ABROGATE THE POOR PROGNOSIS ASSOCIATED WITH HIGH LDH?

Cengiz Seval G., Civriz Bozdağ S., Yüksel M., Topçuoğlu P., Arslan Ö., Özcan M., et al.
7th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Türkiye, 2 - 04 Mayıs 2019, ss.45, (Tam Metin Bildiri)

85. Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?

Ilhan O., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., Topcuoglu P., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37, (Özet Bildiri)

86. Pretransplant hemoglobin and serum creatinine levels correlate with progression free survival in myeloma patients undergoing autologous stem cell transplantation.

DEMİRER T., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2019, cilt.37, (Özet Bildiri)

87. retrospective analysis of 149 unselected patıents wıth mantle cell lymphoma confırms prognostic relevance of mıpı: sıngle center ecperıence

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
ICLLM 2019, 02 Mayıs 2019, (Tam Metin Bildiri)

88. CAN AUTOLOGOUS STEM CELL TRANSPLANTATIONABROGATE THE POOR PROGNOSIS ASSOCIATED WITH HIGHLDH?

SEVAL G. C., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 Mayıs 2019, (Tam Metin Bildiri)

89. CAN ELTROMBOPAG TREAT THE THROMBCYTOPENIA AFTER STEM CELL TRANSPLANTATION

Yüksel M., Kırcalı E., Cengiz Seval G., Koyun D., Uslu A., Öztürk C., et al.
7th International Congress on Leukemia Lymphoma, İstanbul, Türkiye, 2 - 04 Mayıs 2019, (Tam Metin Bildiri)

90. MULTİPLE MYELOM HASTALARINDA OTOLOG PERİFERİK KÖK HÜCRE NAKLİ ESNASINDA GELİŞEN NÖTROPENİK ATEŞ

Uslu A., Cengiz Seval G., Öztürk C., Narlı Özdemir Z., Kırcalı E., Koyun D., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 1 - 02 Mart 2019, sa.142, ss.130, (Tam Metin Bildiri)

91. Refrakter Akut Lösemili Hastalarda Ardışık Kurtarma Tedavisi İle Birlikte Ahkhn Yeterli Kür Sağlayabilir mi?

CENGİZ SEVAL G., KIRCALİ E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Özet Bildiri)

92. Miyelom Hastalarında Ohkhn Öncesi Kullanılan İlaçların Cmv Reaktivasyonu Üzerine Sağkalımı Azaltıcı Etkisi Olabilir mi?

YÜKSEL M., CENGİZ SEVAL G., USLU A., KIRCALİ E., KOYUN D., ÖZTÜRK C., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Özet Bildiri)

93. T-All Hastalarında Allojeneik Hematopoetik Kök Hücre Nakli Sonrasında Nelarabin Tedavisi Graftı Kurtarabilir mi?

CENGİZ SEVAL G., USLU A., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Özet Bildiri)

94. Posttransplant Lenfositoz Önemli Bir Parametre midir?

CENGİZ SEVAL G., USLU A., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Özet Bildiri)

95. Transplant Sonrası Trombositopenide Eltrombopag: Tek Merkez Deneyimimiz

Kırcali E., Cengiz Seval G., Koyun D., Civriz Bozdağ S., Topçuoğlu P., Özcan M., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 1 - 03 Mart 2019, (Tam Metin Bildiri)

96. İyi Riskli Aml’de İkinci Tam Remisyonda Allojeneik Hematopoietik Kök Hücre Nakli Tek Merkez Deneyimi

PEKCAN G., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Özet Bildiri)

97. Allojeneik Kök Hücre Nakli Sonrası Akut Lösemi Hastalarında Nüksü Öngörmede Kimerizm İle Mrd Karşılaştırılması

CENGİZ SEVAL G., ULAŞ B. B., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Özet Bildiri)

98. MİYELOM HASTALARINDA OHKHN ÖNCESİ KULLANILANİLAÇLARIN CMV REAKTİVASYONU ÜZERİNE SAĞKALIMIAZALTICI ETKİSİ OLABİLİR Mİ?

YÜKSEL M., CENGİZ SEVAL G., USLU A., KIRCALI E., KOYUN D., ÖZTÜRK C., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Türkiye, 1 - 03 Mart 2019, (Özet Bildiri)

99. LEUKAPHERESIS REDUCES 4-WEEK MORTALITY IN ACUTEMYELOID LEUKEMIA PATIENTS WITH HYPERLEUKOCYTOSIS - A RETROSPECTIVE STUDY FROM A TERTIARY CENTER

CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 Mayıs 2019, (Tam Metin Bildiri)

100. CAN AUTOLOGOUS STEM CELL TRANSPLANTATIONABROGATE THE POOR PROGNOSIS ASSOCIATED WITH HIGH LDH?

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 Mayıs 2019, (Tam Metin Bildiri)

101. Influence of Conditioning Regimens with Total Body Irradiation (TBI) on Graft Versus Host Disease and Graft Versus Leukemia Effect Following Donor Lymphocyte Infusions (DLI)

CENGİZ SEVAL G., Atilla E., Ulas B., CİVRİZ BOZDAĞ S., TOPRAK S. K., Yuksel M. K., et al.
Transplant and Cell Therapy Meeting / Combined Annual Meetings of the American-Society-for-Blood-and-Marrow-Transplantation (ASBMT) and the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR), Texas, Amerika Birleşik Devletleri, 13 - 24 Şubat 2019, cilt.25, (Özet Bildiri)

102. İmmun Trombositopeni (İTP) hastalarında ABO kan gruplarının birinci basamak tedavi yanıtına etkisi

AKKUŞ E., FİDAN Ç., KUŞTAŞ A. A., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
TKBD Uluslararası Katılımlı Hematolojik Hastalıkların Tanı Ve İzleminde Laboratuvar Sempozyumu, Türkiye, 5 - 07 Nisan 2018, cilt.16, ss.44, (Özet Bildiri)

103. Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Cente Institution Experience

TOPÇUOĞLU P., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., DALVA K., et al.
60th ASH Annual Meeting and Exposition, 01 Aralık 2018, (Tam Metin Bildiri)

104. Comparision of Outcomes According to HLA Disparity in Acute Leukemia Patients: A Single Center Institution Experience

TOPÇUOĞLU P., SEVAL G. C., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., DALVA K., et al.
60th ASH Annual Meeting, san diego, Amerika Birleşik Devletleri, 29 Kasım - 05 Aralık 2018, cilt.132, ss.4673, (Tam Metin Bildiri)

105. Donor Lymphocyte Infusions for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

GÜRMAN G., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 1 - 04 Aralık 2018, cilt.132, (Özet Bildiri)

106. Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients

Atilla E., TOPÇUOĞLU P., AKKUŞ E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 1 - 04 Aralık 2018, cilt.132, (Özet Bildiri)

107. ALLOJENİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILAN ALL HASTALARINDA CMV ENFEKSİYONUNUN NAKİL SONUÇLARINA ETKİLERİ

KALACI E., ŞAHİN EROĞLU D., CENGİZ SEVAL G., NARLI ÖZDEMİR Z., BEKSAÇ M., ÖZCAN M., et al.
44. Ulusal Hematoloji Kongresi, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)

108. Akut Miyeloid Lösemide Nakil Öncesi ve Nakil Sonrası +28. Gün Değerlendirilen Minimal Kalıntı Hastalığın Hastalık Seyrine Etkisi

DALVA K., NARLI ÖZDEMİR Z., ŞAHİN U., USLU A., MURADOVA B., CENGİZ SEVAL G., et al.
44. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.245-246, (Özet Bildiri)

109. ALLOJENİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILANALL HASTALARINDA CMV ENFEKSİYONUNUN NAKİLSONUÇLARINA ETKİLERİ

KALACI E., ŞAHİN EROĞLU D., CENGİZ SEVAL G., NARLI ÖZDEMİR Z., BEKSAÇ M., ÖZCAN M., et al.
44. Ulusal Hematoloji Kongresi, Türkiye, 31 Ekim - 03 Kasım 2018, (Özet Bildiri)

110. AKUT LÖSEMİ HASTALARINDA HLA UYUŞUMSUZLUĞUNUNNAKİL SONUÇLARINA ETKİSİ: TEK MERKEZ DENEYİMİ

CENGİZ SEVAL G., NARLI ÖZDEMİR Z., TATAR L., SÖKMEN M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
44. Ulusal Hematoloji Kongresi, Türkiye, 31 Ekim - 03 Kasım 2018, (Özet Bildiri)

111. Impact of Hepatitis B Core Antibody Seopositivity on the Liver Function Tests after Autologous Hematopoietic Stem Cell Transplantation For Multiple Myeloma

CENGİZ SEVAL G., Sertesen E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., Aslan O., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.338, (Özet Bildiri) Sürdürülebilir Kalkınma

112. The Outcome of Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation for Isolated CD4 (+) T-cell Deficiency with Interleukin-2 Inducible T-cell Kinase (ITK) Gene Defect

YÜKSEL M., Ozdemir Z. N., Sahin U., ÇAĞDAŞ AYVAZ D. N., Atikcan D. T., Sertesen E., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.533-534, (Özet Bildiri)

113. Donor lymphocyte infusion after salvage chemotherapy in relapsed acute myeloblastic leukemia patients after allogeneic stem cell transplantation

Uslu A., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., GÜRMAN G., Demirer T., Arslan O., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.161-162, (Özet Bildiri)

114. Fit Elderly Patients with aggressive lymphoma do not need dose reduction of conditioning regimen

Ilhan O., CENGİZ SEVAL G., Uslu A., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.272-273, (Özet Bildiri)

115. Is post-transplant albumin a predictor of early transplant complications?

TOPÇUOĞLU P., CENGİZ SEVAL G., AKKUŞ E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Lisbon, Portekiz, 18 - 21 Mart 2018, cilt.53, ss.344-345, (Özet Bildiri)

116. Retrospective analysis of 115 unselected patients with mantle cell lymphoma: Single center experience

Cengiz Seval G., BULAT B., Ozel F., Tasci O., Kuzu I., CİVRİZ BOZDAĞ S., et al.
ASCO Annual Meeting 2018, 1 - 05 Haziran 2018, cilt.36, ss.19525, (Tam Metin Bildiri)

117. Allojeneik Hematopoetik Kök Hücre Nakli Sonrası Akut Myeloid Lösemi Nüksünün Yönetimi ve Prognozu

ŞAHİN U., GÜNDÜZ M., MERTER M., NARLI ÖZDEMİR Z., ÖZEN M., CİVRİZ BOZDAĞ S., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 1 - 03 Mart 2018, ss.126-127, (Özet Bildiri)

118. ALLOJENEİK KÖK HÜCRE NAKLİ SONRASI GELİŞENKARACİĞER SİNÜZOİDAL TIKANIKLIK SENDROM İNSİDANSIVE KLİNİK BULGULAR

GÜNDÜZ M., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., ARSLAN Ö., et al.
10. ULUSAL KEMİK İLİĞİTRANSPLANTASYONU VEHÜCRESEL TEDAVİLER KONGRESİ, Antalya, Türkiye, 1 - 03 Mart 2018, (Özet Bildiri)

119. Ph Negatif ALL’de 1. Tam Remisyonda Yapılan Pekiştirme Tedavileri Nakil Sonrası Başarıyı Arttırır

NARLI ÖZDEMİR Z., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 1 - 03 Mart 2018, (Özet Bildiri)

120. MYELOFİBROZİSTE ALLOJENEİK HEMATOPOETİK KÖK HÜCRE NAKLİ SONUÇLARI: TEK MERKEZ DENEYİMİ

CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 01 Mart 2018, (Tam Metin Bildiri)

121. ITK Gen Defektine Bağlı CD4+ T Hücre Yetmezliği Olan Erişkinde Allojeneik Hematopoietik Kök Hücre Naklinin Sonuçları

YÜKSEL M., NARLI ÖZDEMİR Z., ŞAHİN U., CENGİZ SEVAL G., ÇAĞDAŞ AYVAZ D., ATİKCAN D. T., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 01 Mart 2018, ss.138, (Özet Bildiri)

122. Age is Not an Important Factor for Autologous Peripheral Hematopoietic Stem Cell Mobilization and Collection in Patients with Multiple Myeloma

İLHAN O., CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT), Utah, Amerika Birleşik Devletleri, 21 - 25 Şubat 2018, cilt.24, (Özet Bildiri)

123. AKUT GRAFT VERSUS HOST HASTALIĞI KLİNİK SONUÇLARI: TEK MERKEZ DENEYİMİ

NARLI ÖZDEMİR Z., CENGİZ SEVAL G., USLU A., ÖZTÜRK C., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Türkiye, 01 Mart 2018, (Özet Bildiri)

124. KEMOTERAPİ İLE MOBİLİZASYON MULTİPL MİYELOMDA YANITLARI ETKİLİYOR MU?

CENGİZ SEVAL G., USLU A., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., ÖZCAN M., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 01 Mart 2018, (Tam Metin Bildiri)

125. Dilemma-High Response Rates Vs High Toxicity: Autologous Stem Cell Transplantation for Lymphoma

Atilla E., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., Topcuoglu P., Akan H., et al.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, Amerika Birleşik Devletleri, 9 - 12 Aralık 2017, cilt.130, (Özet Bildiri)

126. Age Is Not Important for Autologous Peripheral Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Ilhan O., CENGİZ SEVAL G., TOPRAK S. K., Topcuoglu P., Ozel F., CİVRİZ BOZDAĞ S., et al.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, Amerika Birleşik Devletleri, 9 - 12 Aralık 2017, cilt.130, (Özet Bildiri)

127. Engrafmanın Erken Belirteci: Büyük Boyanmamış Hücreler

Aydın T., MERTER M., ŞAHİN U., Pekcan G., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017, ss.53, (Özet Bildiri)

128. İmmun Trombositopenide (İTP) Yenilikler Işığında Klinik Retrospektif Değerlendirme: Tek Merkez Deneyimi

AKKUŞ E., KUŞTAŞ A. A., Pekcan G., MERTER M., ŞAHİN U., CİVRİZ BOZDAĞ S., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017, ss.98-99, (Özet Bildiri)

129. OTOLOG PERİFERİK KÖK HÜCRE NAKLİNDE KÖK HÜCRESAKLANMA SÜRESİ ENGRAFMAN SÜRESİNİ ETKİLER Mİ?

MERTER M., Güleç B., Özcan G., Zehra Özdemir Z., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017, ss.220, (Özet Bildiri)

130. peripheral blood stem cell mobilization and collection from elderly patients with multiple myeloma:A single center experience

seval G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
ebmt 2017, 26 - 29 Mart 2017, (Özet Bildiri)

131. Peripheral blood stem cell mobilization and collection from elderly patients (≥65 years) with multiple myeloma: A single center experience

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., Topcuoglu P., Arslan O., et al.
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52, (Özet Bildiri)

132. Large unstained cell percentage as a predictor of efficacious peripheral stem cell mobilization in autologous stem cell transplantation

Merter M., Koken K., Yuksel M., Demir E. N., Sahin U., CİVRİZ BOZDAĞ S., et al.
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52, (Özet Bildiri) Sürdürülebilir Kalkınma

133. Herpes simplex virus (HSV) infection in patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT)

Atilla E., Ozel F., Yilmaz V., Atilla P. A., Atesagaoglu B., CİVRİZ BOZDAĞ S., et al.
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52, (Özet Bildiri)

134. Evaluating peritransplant albumin decline as a predictor of acute graft versus host disease

Merter M., Yuksel M., Demir E. N., Sahin U., CİVRİZ BOZDAĞ S., Yuksel M. K., et al.
43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, Fransa, 26 - 29 Mart 2017, cilt.52, (Özet Bildiri)

135. Autologous Stem Cell Trnasplantation for Mantle Cell Lymphoma: A Single Center Exprience

TOPRAK S. K., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
Exprience22nd Congress of the European Hematolgy Association, 22 Haziran - 25 Mayıs 2017, (Özet Bildiri)

136. Allojeneik stem cell transplantation results in our myelodysplastic sydrome (MDS) patientes

GÜRMAN G., ATACA ATİLLA P., AYDIN T., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
patientes53rd Annual Meeting Jun 2-6, 2017, 2 - 06 Haziran 2017, (Özet Bildiri)

137. Comparison of myeloablative vs reduced intensity conditioning regimens in stem cell transplantationd for acute myeloid leukemia

GÜRMAN G., AYDEMİR GULOKSUZ G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
leukemia53rd Annual Meeting, 2 - 06 Haziran 2017, (Özet Bildiri)

138. AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA: SINGLE CENTER EXPERIENCE

TOPRAK S. K., Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., Topcuoglu P., et al.
22nd Congress of the European-Hematology-Association, Madrid, İspanya, 22 - 25 Haziran 2017, cilt.102, ss.865, (Özet Bildiri)

139. A biosimilar G-CSF filgrastim is as effective as a reference drug, however, it is not as cost effective as it supposed to be

PEKCAN G., YÜKSEL M., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
6th International Congress on Leukemia Lymphoma Myeloma, Antalya, Türkiye, 11 - 13 Mayıs 2017, ss.112, (Özet Bildiri)

140. Large Unstained Cell Percentage as a Predictor of Efficacious Peripheral Stem Cell Mobilization

MERTER M., KÖKEN K., YÜKSEL M., NURDAN DEMİR E., ŞAHİN U., CİVRİZ BOZDAĞ S., et al.
6th International Congress on Leukemia Lymphoma Myeloma, 11 - 13 Mayıs 2017, (Özet Bildiri)

141. Comparison of myeloablative vs reduced intensity conditioning regimens in stem cell transplantations for acute myeloid leukemia.

GÜRMAN G., Guloksuz G. A., Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35, (Özet Bildiri)

142. A single center experience with two decades of follow-up on patients with hairy cell leukemia.

İLHAN O., Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, Amerika Birleşik Devletleri, 2 - 07 Haziran 2017, cilt.35, (Özet Bildiri)

143. Acute GVHD and unreated/haploidentical Trnasplants incrreses the incidence of hemorrhagic cystitis in Allo- HSCT Recipients

TOPÇUOĞLU P., ATİLLA E., ATACA ATİLLA P., USLU A., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
43rd Annual Meeting Of EBMT, 26 - 29 Mart 2017, (Özet Bildiri)

144. Herpes SimplexVirus infection in patients after allogeneic hematopoetic stem cell transplantation

ATİLLA E., ÖZEL F., YILMAZ V., ATACA ATİLLA P., ATEŞAĞAOĞLU B., CİVRİZ BOZDAĞ S., et al.
43rd Annual Meeting Of EBMT, 26 - 29 Mart 2017, (Özet Bildiri)

145. Large Unsatained Cell (LUC) percentage as a predictor of efficacious peripheral stem cell mobilization in autologous stem cell transplantation

MERTER M., KÖKEN K., YÜKSEL M., DEMİR N., ŞAHİN U., CİVRİZ BOZDAĞ S., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 Mart 2017, (Özet Bildiri)

146. Evalauting peritransplant albümin decline as a predictor os acute graft versus host disease

MERTER M., YÜKSEL M., NURDAN DEMİR E., ŞAHİN U., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., et al.
43rdAnnual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 Mart 2017, (Özet Bildiri)

147. Peripheral blood stem cell mobilization and collection from elderly patients (265 years) with multiple myeloma: A single center experience

CENGİZ SEVAL G., TOPRAK S. K., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 Mart 2017, (Tam Metin Bildiri)

148. Catheter Thrombosis in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) Recipients

GÜRMAN G., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
BMT Tandem Meetings, 22 - 26 Şubat 2017, (Özet Bildiri)

149. Comparison of Reduced Intensity Conditioning (RIC) Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for Adult Patients with Acute Leukemia

GÜRMAN G., gülöksüz g., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
58th ASH, 3 - 06 Aralık 2016, cilt.128, (Özet Bildiri)

150. Therapeutic Plasma Exchange for Thrombotic Microangiopathy

İLHAN ., Atilla E., Atilla P. A., Bozdag S. C., Yuksel M. K., TOPRAK S. K., et al.
58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 3 - 06 Aralık 2016, cilt.128, (Özet Bildiri)

151. Comparison of Reduced Intensity Conditioning (RIC) Regimen and Myeloablative Conditioning (MAC) Regimen in Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for Adult Patients with Acute Leukemia

GÜRMAN G., Guloksuz G. A., Atilla E., Atilla P. A., CİVRİZ BOZDAĞ S., YÜKSEL M., et al.
58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 3 - 06 Aralık 2016, cilt.128, (Özet Bildiri)

152. PERİFERİK T HÜCRELİ LENFOMALARDA OTOLOGHEMATOPOETİK KÖK HÜCRE TRANSPLANTASYONU TEK MERKEZ DENEYİMİ

ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016

153. ALLOJENEİK KÖK HÜCRE NAKLİ YAPILANHASTALARDA PERİTRANSPLANT ALBUMİN DÜŞÜŞÜİLE GVHD İLİŞKİSİ

MERTER M., Şah F. T., ŞAHİN U., YALÇINER M., Kocabay H. E., CİVRİZ BOZDAĞ S., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016

154. TROMBOTİK MİKROANJİOPATİDE TERAPÖTİKPLAZMA DEĞİŞİMİ

ATİLLA E., ATACA ATİLLA P., TOPRAK S. K., TOPÇUOĞLU P., YÜKSEL M., CİVRİZ BOZDAĞ S., et al.
42. Ulusal Hematoloji, Türkiye, 19 - 22 Ekim 2016

155. AllojeneikKökHücreNakliHastalarımızdaGelişenKataterTrombozları

ATİLLA E., YALÇINER M., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
ULUSAL HEMATOLOJİ 2016, Türkiye, 18 - 22 Ekim 2016, (Özet Bildiri)

156. ALLOJENEİK KÖK HÜCRE NAKLİ OLAN AKUTLÖSEMİLERDE HAZIRLIK REJİMLERİNİNKARŞILAŞTIRILMASI

GÜLÖKSÜZ G. A., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016

157. ANTİ HLA ANTİKOR VARLIĞININ ALLOJENEİK KÖKHÜCRE NAKLİ YAPILAN HASTALARDA ENGRAFMANÜZERİNE ETKİSİ TEK MERKEZ DENEYİMİ

MERTER M., AYDOĞAN M., TEKEŞ M. A., ŞAHİN U., AYYILDIZ Ö. M., KOCABAY H. E., et al.
42. Ulusal Hematoloji Kongresi, Türkiye, 19 - 22 Ekim 2016

158. AllojeneikKökHücreNakli Olan AkutLösemilerdeHazırlıkRejimlerininKarşılaştırılması

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., TOPÇUOĞLU P., et al.
ULUSAL HEMATOLOJİ 2016, Türkiye, 18 - 22 Ekim 2016, (Özet Bildiri)

159. Approach to Hairy Cell Leukemia HCL 31 years of Experience

KIRCALI E., ATACA ATİLLA P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
EHA 2016, 9 - 12 Haziran 2016, (Özet Bildiri)

160. Age as a dicision factor for doing autuologous stem cell transplantation in fit patients with myeloma and lymphoma ASCO Annual Meeting J Clin Oncol 34 2016 suppl abstr e 19001

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
ASCO, 3 - 07 Haziran 2016

161. Age as a decision factor for doing autuologous stem cell transplantation in fit patients with myeloma and lymphoma

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
2016 ASCO Annual Meeting., 3 - 07 Haziran 2016, (Özet Bildiri)

162. Age as a decision factor for doing autologous stem cell transplantation in fit patients with myeloma and lymphoma Subcategory

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
ASCO 2016, ABD, 3 - 07 Haziran 2016, (Özet Bildiri)

163. Are Age and JAK2V617F Mutation Related to Trombosis in Chronic Myeloproliferative Diseases

ATİLLA E., ATACA ATİLLA P., TOPRAK S. K., KAYGUSUZ G., KUZU I., CİVRİZ BOZDAĞ S., et al.
24th Biennial International Congress on Thrombosis, 4 - 07 Mayıs 2016, (Özet Bildiri)

164. Age as a decision factor for doing autologous stem cell transplantation in fit patients with myeloma and lymphoma.

Ilhan O., Atilla E., Ataca P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34, (Özet Bildiri)

165. THERAPEUTIC THROMBOCYTAPHERESIS: HIGHER PLATELET COUNTS SHOULD MATTER

Narli Z., Sahin U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPRAK S. K., Topcuoglu P., et al.
24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Türkiye, 4 - 07 Mayıs 2016, cilt.141, (Özet Bildiri)

166. THERAPEUTIC PLASMA EXCHANGE FOR THROMBOTIC MICROANGIOPATHY

Atilla E., Ataca P., Sahin U., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Türkiye, 4 - 07 Mayıs 2016, cilt.141, (Özet Bildiri)

167. Age as a dicision factor for doing autuologous stem cell transplantation in fit patients with myeloma and lymphoma

İLHAN O., ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., et al.
ASCO, 3 - 07 Haziran 2016, (Özet Bildiri)

168. PAROKSİSMAL NOKTÜRNAL HEMOGLOBİNÜRİHASTALARINDA ALLOJENEİK HEMATOPOETİK KÖKHÜCRE NAKLİ TEK MERKEZ DENEYİMİ

NARLI ÖZDEMİR Z., TOPRAK S. K., TOPÇUOĞLU P., ŞAHİN U., GÜNDÜZ M., ATİLLA E., et al.
9.Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Türkiye, 3 - 05 Mart 2016

169. AKTİF HASTALIKLI AKUT LÖSEMİDE ATG VEHAZIRLIK REJİMİ İLE ALLOJENİK NAKİL SONRASICMV REAKTİVASYONUNUN PROGNOZA ETKİSİ

GÜNDÜZ M., ŞAHİN U., MERTER M., NARLI ÖZDEMİR Z., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
9.Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Türkiye, 3 - 05 Mart 2016

170. Effect of Cytomegalovirus Reactivation on Prognosis After Allogeneic Transplantation for Acute Leukemia with Active Disease Conditioned with a Sequential Regimen and Anti-Thymocyte Globulin

Gunduz M., YÜKSEL M., Sahin U., Merter M., Ozdemir Z. N., CİVRİZ BOZDAĞ S., et al.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, İspanya, 3 - 06 Nisan 2016, cilt.51, (Özet Bildiri)

171. Clinical Characteristics and Frequency of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation

Sahin U., YÜKSEL M., Merter M., Gunduz M., Ozdemir Z. N., CİVRİZ BOZDAĞ S., et al.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, İspanya, 3 - 06 Nisan 2016, cilt.51, (Özet Bildiri)

172. Efficacy of High Dose Corticosteroid Premedication for the Prevention of Anti-thymocyte Globulin Related Side Effects

Merter M., Sahin U., Atilla E., CİVRİZ BOZDAĞ S., YÜKSEL M., Topcuoglu P., et al.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, İspanya, 3 - 06 Nisan 2016, cilt.51, (Özet Bildiri)

173. HAİRY CELL LÖSEMİ HCL VAKALARIMIZ TEKMERKEZ DENEYİMİ

Kırcalı E., ATACA P., ATİLLA E., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
41.Ulusal Hematoloji Kongresi, Türkiye, 21 - 24 Ekim 2015

174. Clinical Allogeneic Transplantation Acute and Chronic GVHD Immune Reconstitution

GÜRMAN G., ATACA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
57th ASH Annual Meeting & Exposition, 5 - 08 Aralık 2015

175. Comparison of Two Different Doses of Corticosteroid Premedication for Antithymocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation

Merter M., Atilla E., Sahin U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri)

176. Is Initial CD3+T Cell Dose in Donor Lymphocyte Infusion for Relapsed Hematological Malignancies a Prognostic Determinant?

Atilla E., Ataca P., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri)

177. Positive Impact of Chronic Graft-Versus Host Disease on Survival in 928 Allogeneic Hematopoietic Stem Cell Transplant Recipients

GÜRMAN G., Ataca P., Atilla E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri)

178. Allojeneik Hematopoietik Kök Hücre Nakli AHKHN Hastalarında Gelişen Üst ve Alt Solunum Yolları Viral Enfeksiyonları

ATİLLA E., ATACA P., ŞAHİN D., DOLAPÇI G. İ., TEKELİ F. A., CİVRİZ BOZDAĞ S., et al.
Febril Nötropeni Simpozyumu, Türkiye, 28 - 30 Kasım 2015, (Özet Bildiri)

179. Ph Negatif ALL Hastalarında Allojenik Kök Hücre Nakli Öncesi Tedavilerin Klinik Seyir ile İlişkisi

NARLI ÖZDEMİR Z., EKİN K., ATACA P., ATİLLA E., TOPÇUOĞLU P., CİVRİZ BOZDAĞ S., et al.
41. Ulusal Hematoloji Kongresi, Türkiye, 21 - 24 Ekim 2015

180. allojeneik hematopoietik kök hücre nakli yapılan hastalarda anti HLA antikorları ile engrafman yetmezliği ilişkisi tek merkez deneyimi

MERTER M., ŞAHİN U., ataşağaoğlu b., TUTKAK H., TOPRAK S. K., YÜKSEL M., et al.
41. Ulusal Hematoloji Kongresi, Türkiye, 21 - 24 Ekim 2015, (Özet Bildiri)

181. allojeneik hematopoietik kök hücre naklinde iki farklı antitimosit globulin premedikasyon protokolünün karşılaştırılması

MERTER M., ATİLLA E., ŞAHİN U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
ulusal hematoloji kongresi 2015, Türkiye, 21 - 24 Ekim 2015

182. ALLOJENEİK KÖK HÜCRE TRANSPLANTASYONHASTASINDA KRONİK GRAFT VERSUS HOSTHASTALIĞININ GENEL SAĞKALIM ÜZERİNE ETKİSİ

ATİLLA E., ATACA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., DEMİRER T., et al.
41. Ulusal Hematoloji Kongresi, Türkiye, 21 - 24 Ekim 2015

183. 928 ALLOJENEİK KÖK HÜCRE TRANSPLANTASYONHASTASINDA KRONİK GRAFT VERSUS HOSTHASTALIĞININ GENEL SAĞKALIM ÜZERİNE ETKİSİ

ATİLLA E., ATACA ATİLLA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., DEMİRER T., et al.
41. Ulusal Hematoloji Kongresi, Türkiye, 21 - 24 Ekim 2015, (Özet Bildiri)

184. Allojeneik Hematopoietik Kök Hücre Naklinde İki Farklı Antitimosit Globulin Premedikasyon Protokolünün Karşılaştırılması

MERTER M., ATİLLA E., ŞAHİN U., CİVRİZ BOZDAĞ S., YÜKSEL M., TOPÇUOĞLU P., et al.
41. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 21 - 24 Ekim 2015, ss.71-72, (Özet Bildiri)

185. PH NEGATİF ALL HASTALARINDA ALLOJENİK KÖKHÜCRE NAKLİ ÖNCESİ TEDAVİLERİN KLİNİK SEYİRİLE İLİŞKİSİ

Özdemir Z. N., Kırcalı E., ATACA P., ATİLLA E., TOPÇUOĞLU P., CİVRİZ BOZDAĞ S., et al.
41.Ulusal Hematoloji Kongresi, Türkiye, 21 - 24 Ekim 2015

186. Allojeneik Hematopoietik Kök Hücre Nakli Yapılan Hastalarda Anti HLA Antikorları ile Engrafman Yetmezliği İlişkisi: Tek Merkez Deneyimi

MERTER M., ŞAHİN U., ATEŞAĞAOĞLU B., TUTKAK H., TOPRAK S. K., YÜKSEL M., et al.
41. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 21 - 24 Ekim 2015, (Özet Bildiri)

187. ALLOJENEİK HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILAN HASTALARDA ANTİ HLA ANTİKORLARI İLE ENGRAFMAN YETMEZLİĞİ İLİŞKİSİ TEK MERKEZ DENEYİMİ

MERTER M., ŞAHİN U., ateşağaoğlu b., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
41.Ulusal Hematoloji Kongresi, Türkiye, 21 - 23 Ekim 2015, (Özet Bildiri)

188. ALLOJENEİK HEMATOPOİETİK KÖK HÜCRENAKLİNDE İKİ FARKLI ANTİTİMOSİTGLOBULİN PREMEDİKASYON PROTOKOLÜNÜNKARŞILAŞTIRILMASI

MERTER M., ŞAHİN U., Ateşağaoğlu B., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., et al.
41.Ulusal Hematoloji Kongresi, Türkiye, 21 - 24 Ekim 2015

189. HODGKİN HL VE HODGKİNDIŞI LENFOMALI HDL HASTALARDA TEDAVİ SONRASI GEÇ DÖNEMDEYÜKSEK HEMATOKRİT DEĞERLERİ HL İLEERİTROSİTOZ ARASINDA İLİŞKİ Mİ VAR

Ateşağaoğlu B., ATACA P., Tuncay G., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
41. Ulusal Hematoloji Kongresi, Türkiye, 21 - 24 Ekim 2015

190. Allagenic stemcell transplantation results in our myelodysplastic syndrome MDS patient

GÜRMAN G., ATACA P., AYDIN T., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
ASCO -2015, 29 - 02 Mayıs 2015

191. Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Allo HSCT A Single Center Experience 41st Annual Meeting of the European Society for Blood and

MERTER M., uğur ş., gündüz m., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
(Allo-HSCT): A Single Center Experience. 41st Annual Meeting of the European Society for Blood and Marrow Transplantation, Istanbul, 22-25 Mayıs 2015., 22 - 25 Mayıs 2015, (Tam Metin Bildiri)

192. Allogeneic Stem Cell Transplantation for Hodgkin and non Hodgkin Lymphoma

ATACA P., ATİLLA E., CİVRİZ BOZDAĞ S., TOPRAK S. K., TOPÇUOĞLU P., ARSLAN Ö., et al.
5th International Congress on Lymphoma Leukemia Myeloma, İstanbul, Turkey, 21-23 May 2015. Turkish Society of Hematology, Proceedings & Abstract Book, abstract # 0109, poster # PS-101 pp 175., 21 - 23 Mayıs 2015

193. AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY PATIENTS 60 YEARS WITH MYELOMA OR LYMPHOMA

ATİLLA E., GÜNDÜZ M., ATACA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., MELTEM K. Y., et al.
5th International Congress on Lymphoma Leukemia Myeloma, İstanbul, Turkey, 21 - 23 Mayıs 2015, (Özet Bildiri)

194. Allogeneic stem cell transplantation results in our myelodysplastic syndrome (MDS) patients.

GÜRMAN G., Ataca P., Aydin T., Atilla E., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)

195. Autologous Stem Cell Transplantation in Elderly Patients with Myeloma or Lymphoma

ATİLLA E., MEHMET G., ATACA P., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
Best of ASBMT Tandem Meetings, Poster Presentation, Türkiye, 27 - 28 Mart 2015

196. THE RELAPSE IN Acute leukemıa after the allogeneıc hematopoetıc stem cell transplantatıon: no approaches have been superıor yet

TOPÇUOĞLU P., GÜNDÜZ M., ÖZEN M., ATİLLA E., ATACA P., CİVRİZ BOZDAĞ S., et al.
41st The European Society for Blood and Marrow Transplantation, 22 - 25 Mart 2015, (Özet Bildiri)

197. DIFFERENT DOSES OF ATG IN THE CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

PEKCAN G., ATEŞAĞAOĞLU B., MERTER M., TOPÇUOĞLU P., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41.EBMT MEETING, 24 - 26 Mart 2015

198. ımpact pf pretransplant serum ferritinon outcomes of allogeenic hematopoeitic stem cell transplantationfor acute leukemia

ŞAHİN U., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., TOPÇUOĞLU P., ARSLAN Ö., et al.
41.ebmt meeting, 22 - 25 Mart 2015

199. THE RELAPSE IN ACUTE LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION NO APPROACHES HAVE BEEN SUPERIOR YET

TOPÇUOĞLU P., GÜNDÜZ M., ÖZEN M., ATİLLA E., ATACA P., CİVRİZ BOZDAĞ S., et al.
41.EBMT MEETING, 24 - 26 Mart 2015

200. Autologus stem cell transplantation in elderly patients with myeloma and lymphoma single center experience

GÜNDÜZ M., ATİLLA E., ATACA P., PEKCAN G., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41.EBMT KONGRESİ, 24 - 26 Mart 2015

201. Different Doses of Anti Thymocyte Globulin ATG in the Conditioning Regimen for Allogeneic Hematopoetic Stem Cell Transplantation 22 25 March 2015 Bone Marrow Transplant 2015 50 S1 S228

GÜLTEKİN P., ATEŞAĞAOĞLU B., MERTER M., TOPÇUOĞLU P., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41st Annual Meeting of the European Society for Blood and Marrow Transplantation Istanbul, Turkey, 22 - 25 Mart 2015, (Özet Bildiri)

202. Prognosis of Acute Leukemia Patients with Active Disease Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Allo HSCT 22 25 March 2015 Bone Marrow Transplant 2015 50 S1 S483

UĞUR Ş., MERTER M., ATAŞAĞAOĞLU B., ERDAL H., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41st Annual Meeting of the European Society for Blood and Marrow Transplantation Istanbul, Turkey, 22 - 25 Mart 2015, (Özet Bildiri)

203. Upper and Lower Respiratory Tract Infections by Respiratory Viruses by Respiratory Viruses in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Single Center Experience

ŞAHİN D., ATİLLA E., CİVRİZ BOZDAĞ S., ATACA P., TOPRAK S. K., TOPÇUOĞLU P., et al.
41th EBMT Meeting, 22 - 25 Mart 2015, (Özet Bildiri)

204. Generic Bioequivalent Melphalan Has Similar Efficacy and Toxicity but Lower Cost in the Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation 22 25 March 2015 Bone Marrow Transplant 2015 50 S1 S440

TOPÇUOĞLU P., GÜLTAY D., ÖZTÜRK N., KILIÇ Ö., OKAY M., ERASLAN KARADAĞ Y., et al.
41st Annual Meeting of the European Society for Blood and Marrow Transplantation Istanbul, Turkey, 22 - 25 Mart 2015, (Özet Bildiri)

205. s it possible to overcome the catastrophic complications of Hematopoietic Stem Cell Transplantation HSCT using Plasma Exchange PE A Single Center s Experience

YÜKSEL M., Gultekin G., Edipoglu E., Bay M., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, 22 - 25 Mart 2015, (Özet Bildiri)

206. Are there any optimal cell doses for graft repopulation in the Bone Marrow-Derived Allogeneic Hematopoietic Stem Cell Transplantations?

Ataca P., Atilla E., Altas U., Bay M., Dalva K., CİVRİZ BOZDAĞ S., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, (Özet Bildiri)

207. Different Doses of Anti-Thymocyte Globulin (ATG) in the Conditioning Regimen for Allogeneic Hematopoetic Stem Cell Transplantation

Pekcan G., Atesagaoglu B., Merter M., Topcuoglu P., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, (Özet Bildiri)

208. Allogeneic Stem-Cell Transplantation for Hodgkin and non-Hodgkin Lymphoma: Single-center experience

Atilla E., Aydin T., Merter M., Ataca P., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, ss.5619, (Özet Bildiri)

209. Generic (Bioequivalent) Melphalan Has Similar Efficacy and Toxicity but Lower Cost in the Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation

Topcuoglu P., Gultay D., Ozturk N., Kilic O., Okay M., Karadag Y. E., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, (Özet Bildiri)

210. The relapse in acute leukemia after the allogeneic hematopoetic stem cell transplantation: No approaches have been superior yet

Topcuoglu P., Gunduz M., Ozen M., Ataca P., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, (Özet Bildiri)

211. Impact of Pre-transplant Serum Ferritin on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia

Sahin U., Erdal H., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., Topcuoglu P., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, (Özet Bildiri)

212. Extramedullary Relapse of Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT): A Single Center Experience

Merter M., Sahin U., Gunduz M., Atilla E., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, (Özet Bildiri)

213. Upper and lower respiratory tract infections by respiratory viruses in adult recipients of allogeneic hematopoeitic stem cell transplantation (Allo-HSCT): Single center

Sahin D., Atilla E., Ataca P., DOLAPÇI G. İ., TEKELİ F. A., Uslu A., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, (Özet Bildiri)

214. Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria: Single Centre Experience

Merter M., Sahin U., Atilla E., CİVRİZ BOZDAĞ S., TOPRAK S. K., YÜKSEL M., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, (Özet Bildiri)

215. Is it possible to overcome the catastrophic complications of Hematopoietic Stem Cell Transplantation (HSCT) using Plasma Exchange (PE)?: A Single Center's Experience

YÜKSEL M., Pekcan G., Ediboglu E., Bay M., Civriz S., TOPRAK S. K., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, ss.5581-5582, (Özet Bildiri)

216. Autologous Stem Cell Transplantation in Elderly Patients ( >=60 years) with Myeloma or Lymphoma: Single Center Experience

Gunduz M., Atilla E., Ataca P., Pekcan G., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, ss.5622, (Özet Bildiri)

217. Prognosis of Acute Leukemia Patients with Active Disease Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Sahin U., Merter M., Atesagaoglu B., Erdai H., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Türkiye, 22 - 25 Mart 2015, cilt.50, (Özet Bildiri)

218. Is R-CODOX-M/IVAC Inferior to Other Regimens in Burkitt's Lymphoma: A Single Center Experience

Atilla E., Sahin U., Ataca P., Uslu A., Kircali E., Atesagaoglu B., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)

219. Fertility in Our Allogeneic Hematopoietic Stem Cell Transplant Patients

TOPÇUOĞLU P., Ataca P., CİVRİZ BOZDAĞ S., TOPRAK S. K., ARSLAN Ö., ÖZCAN M., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)

220. Is the Chronic Myeloproliferative Disease Prognosis Really Different in Geriatric Patients?

İLHAN O., Ataca P., Atilla E., TOPRAK S. K., KAYGUSUZ G., KUZU I., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)

221. Clinical Reflection of Immunophenotyping in Paroxysmal Nocturnal Hemoglobinuria: Experience of a Single Center

Sahin U., Merter M., Ataca P., Atilla E., Atesagaoglu B., Pekcan G., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)

222. Treatment Approaches in Acute Leukemia Patients Relapsing Following Allogeneic Hematopoietic Stem Cell Transplantation

TOPÇUOĞLU P., Gunduz M., Ozen M., CİVRİZ BOZDAĞ S., TOPRAK S. K., ARSLAN Ö., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)

223. Do FMS-like Tyrosine Kinase 3 and Nucleophospmin 1 Gene Mutations Really Effect Survival in Acute Myeloid Leukemia ?

Gunduz M., Ataca P., Ozen M., Atilla E., CİVRİZ BOZDAĞ S., TOPRAK S. K., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)

224. FMS Benzeri Tirozin Kinaz 3 ve Nükleofosmin 1 Gen Mutasyonlarının Akut Myeloid Lösemide Sağkalıma Etkisi

gündüz m., ATACA P., ÖZEN M., akfırat h., ATİLLA E., CİVRİZ BOZDAĞ S., et al.
40. Ulusal Hematoloji Kongresi, Türkiye, 22 - 25 Ekim 2014, ss.18-19, (Özet Bildiri)

225. R-CODOX-M/IVAC Burkitt Lenfoma’da Diğer Tedavi Rejimlerinden Gerçekten Üstün Mü? Tek Merkez Deneyimi

ATİLLA E., ŞAHİN U., ATACA P., USLU A., KİRÇALI E., ATEŞAĞAOĞLU B., et al.
40. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 22 - 25 Ekim 2014, ss.39-40, (Özet Bildiri)

226. STEM CELL MOBILIZASTION IN ELDERLY MULTIPLE MYELOMA PATIENTS: SINGLE CENTER EXPERIENCE

TOPRAK S. K., CENGİZ SEVAL G., AYYILDIZ E., TOPÇUOĞLU P., ARSLAN Ö., ÖZCAN M., et al.
19th Congress of the European Hematology Association, 12 Haziran 2014, (Tam Metin Bildiri)

227. STEM CELL MOBILIZATION IN ELDERLY MULTIPLE MYELOMA PATIENTS: SINGLE CENTER EXPERIENCE

TOPRAK S. K., CENGİZ SEVAL G., Ayyildiz E., Topcuoglu P., Arslan O., Ozcan M., et al.
19th Congress of the European-Hematology-Association, Milan, İtalya, 12 - 15 Haziran 2014, cilt.99, ss.721, (Özet Bildiri)

228. İnşaat sırasında meydana gelebilecek hematolojik infeksiyonların engellenmesi

ÖZEN M., YILMAZ G., ÇOŞKUN B., TOPÇUOĞLU P., ÖZTÜRK B., GÜNDÜZ M., et al.
İnfeksiyon dünyası çalıştayı, Türkiye, 20 Şubat - 23 Mart 2014, (Özet Bildiri)

229. OTOLOG HEMATOPOETİK KÖK HÜCRE NAKLİ SONRASINDA GELİŞEN BİR CMV RETİNİT VAKASI

CENGİZ SEVAL G., TOPÇUOĞLU P., İDEMEN C., DEMİRER T.
8. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 06 Mart 2014, (Özet Bildiri)

230. AKRABA DIŞI ALLOJENEİK HEMATOPOETİK HÜCRE NAKLİNDE HLA UYUŞUMUNUN ETKİSİ-TEK MERKEZ DENEYİMİ

CENGİZ SEVAL G., TOPÇUOĞLU P., ÖZEN M., GÜNDÜZ M., ATİLLA E., DALVA K., et al.
8. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 06 Mart 2014, (Özet Bildiri)

231. Management of Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation

GÜRMAN G., Atilla E., Ozen M., Kubilay P., Yilmaz G., Gunduz M., et al.
BMT Tandem Meetings, Texas, Amerika Birleşik Devletleri, 26 Şubat - 02 Mart 2014, cilt.20, (Özet Bildiri) Creative Commons License

232. Comparison Of Flow Cytometric and Clinical Findings In Patients With Paroxysmal Nocturnal Hemoglobinuria

Demirer T., Baslar S., Uysal V. A., Beksac M., Ozen M., Konuk N., et al.
55th Annual Meeting of the American-Society-of-Hematology, Louisiana, Amerika Birleşik Devletleri, 7 - 10 Aralık 2013, cilt.122, (Özet Bildiri)

233. Paroksismal Noktürnal Hemoglobinüride İmmünfenotipleme Çalışmalarının Kliniğe Yansıması: Tek Merkez Deneyimi

ŞAHİN U., MERTER M., ATACA P., ATİLLA E., ATEŞAĞAOĞLU B., PEKCAN G., et al.
40. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 22 - 25 Ekim 2013, ss.131, (Özet Bildiri)

234. Aldehyde hydrogenase activity in mobilized peripheral stem cell products and its relationship with engraftment

CİVRİZ BOZDAĞ S., Topcuoglu P., Ozkan M., Ilhan O. I., Arslan O., Demirer T., et al.
39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, Kanada, 7 - 10 Nisan 2013, cilt.48, (Özet Bildiri)

235. Peripheral stem cell apheresis in multiple myeloma in the era of new agents

Bakanay S. M., Ayyildiz E., Arat M., Topcuoglu P., Soydan E., Dalva K., et al.
37th European Group for Bone and Marrow Transplantation/27th Meeting of the EBMT Nurses Group/10th Meeting of the EBMT Management Group, Paris, Fransa, 3 - 06 Nisan 2011, cilt.46, (Özet Bildiri)

236. Comparison of two different chemotherapy regimens for peripheral blood stem cell mobilization in lymphoma

CİVRİZ BOZDAĞ S., Topcuoglu P., Bakanay S. M., Arat M., Soydan E., Ozcan M., et al.
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Avusturya, 21 - 24 Mart 2010, cilt.45, (Özet Bildiri)

237. High-dose chemotherapy with autologous stem-cell support versus standard-dose chemotherapy: meta-analysis of individual patient data from 6 randomised metastatic breast cancer trials

Demirer T., Ueno N., Johnson M., Bregni M., Berry D. A.
35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg, İsveç, 29 Mart - 01 Nisan 2009, cilt.43, (Özet Bildiri)

238. The effect of rituximab in first line therapy to results of autologus haematopoietic stem cell transplantation in relapsed non-Hodgkin's lymphoma patients

CİVRİZ BOZDAĞ S., Topcuoglu P., Bakanay S., Arat M., Ilhan O., BEKSAÇ M., et al.
35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg, İsveç, 29 Mart - 01 Nisan 2009, cilt.43, (Özet Bildiri)

239. High-dose chemotherapy with autologous stem-cell support versus standard-dose chemotherapy: meta-analysis of individual patient data from 6 randomized metastatic breast cancer trials

Berry D. A., Ueno N. T., Johnson M. M., Lei X., Smith D. A., Caputo J., et al.
31st Annual San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 10 - 14 Aralık 2008, cilt.69, (Özet Bildiri)

240. Long-term outcome in adult Ewing's sarcoma patients treated with high-dose chemotherapy: results of a retrospective analysis from the EBMT

Bertuzzi A., Tienghi A., Peccatori F., Pedrazzoli P., Stroppa E., Salamina S., et al.
34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group, Florence, İtalya, 30 Mart - 02 Nisan 2008, cilt.41, (Özet Bildiri)

241. High-dose chemotherapy with autologous stem-cell support versus standard-dose chemotherapy: meta-analysis of individual patient data from 15 randomised adjuvant breast cancer trials

Demirer T., Ueno N. N., Bregni M., Berry D.
34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group, Florence, İtalya, 30 Mart - 02 Nisan 2008, cilt.41, (Özet Bildiri)

242. Allogeneic stem cell transplantation in ovarian cancer: the EBMT experience

Bay J. O., Tabrizi R., Blaise D., Viens P., Ehninger G., Bornhauser M., et al.
34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group, Florence, İtalya, 30 Mart - 02 Nisan 2008, cilt.41, (Özet Bildiri)

243. High-dose chemotherapy with autologous stem-cell support versus standard-dose chemotherapy: meta-analysis of individual patient data from 15 randomized adjuvant breast cancer trials

Berry D. A., Ueno N. T., Johnson M. M., Lei X., Lopez V., Caputo J., et al.
30th Annual San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 13 - 16 Aralık 2007, cilt.106, (Özet Bildiri) Sürdürülebilir Kalkınma

244. The impact of disparity in short tandem repeats (STRS) analysis on the outcome of allogeneic hematopoietic cell transplantation (allo-HCT) from HLA-identical sibling donors

Serbest E., Topcuoglu P., Dalva K., Soydan E. S., Arslan O. A., Ozcan M. O., et al.
12th Congress of the European-Hematology-Association, Vienna, Avusturya, 7 - 10 Haziran 2007, cilt.92, ss.517, (Özet Bildiri)

245. The impact of disparity in short tandem repeats analysis on the outcome of allogeneic haematopoietic cell transplantation from HLA-identical sibling donors

Serbest E., Topcuoglu P., Dalva K., Soydan E. A., Arslan O., Ozcan M., et al.
33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, Fransa, 25 - 28 Mart 2007, cilt.39, (Özet Bildiri)

246. Impact of histopathological subtype of cutaneous chronic GvHD on alloHSCT outcome: Iichenoid versus scleradermoid

Soydan E. A., Cengiz G., Sanli H. E., Topcuoglu P., Bilgin A. U., Bakanay S. M., et al.
33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, Fransa, 25 - 28 Mart 2007, cilt.39, (Özet Bildiri)

247. The impact of pretransplant imatinib use in allogeneic haematopoietic cell transplantation for CML:: a single-centre comparative analysis

Bilgin A. U., Soydan E. A., Topcuoglu P., Gunaydan Y., Uysal A., Konuk N., et al.
33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, Fransa, 25 - 28 Mart 2007, cilt.39, (Özet Bildiri)

248. Time intervals preceeding autologous stem cell transplantation in multiple myeloma patients: a single-centre intent to transplant analysis

Arat M., Cakar M. K., Soydan E. A., Topcuoglu P., Bilgin A. U., Bakanay S. M., et al.
33rd Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Lyon, Fransa, 25 - 28 Mart 2007, cilt.39, (Özet Bildiri)

249. The impact of histopathological subtype of cutaneous chronic GvHD on alloHSCT outcome: lichenoid versus scleradermoid

SOYDAN E., CENGİZ SEVAL G., ŞANLI H., TOPÇUOĞLU P., UĞUR BİLGİN A., BAKANAY ÖZTÜRK Ş. M., et al.
33nd Annual Meeting of the European Society for Blood and Marrow Transplantation, 25 Mart 2007, (Tam Metin Bildiri)

250. Allogeneic hematopoietic cell transplantation in imatinib era: A single center comparative analysis of imatinib receiving patients to imatinib naive patients

Ugur B. A., Soydan E., Topcuoglu P., Arsdan O., Ozcan M., GÜRMAN G., et al.
Tandem BMT Meeting 2007, Colorado, Amerika Birleşik Devletleri, 8 - 12 Şubat 2007, cilt.13, ss.100-101, (Özet Bildiri)

251. MULTİPL MİYELOMA VE MALİN LENFOMALI HASTALARDA OTOLOG PERİFERİK KÖK HÜCRE TOPLANMASINDA AFEREZ GÜN SAYISI ÖNGÖRÜLEBİLİR Mİ? - ANKARA HESAPLAMA FORMÜLÜ

ARAT M., CENGİZ SEVAL G., SOYDAN E., AYYILDIZ E., TOPÇUOĞLU P., ARSLAN Ö., et al.
32. Ulusal Hematoloji Kongresi, 08 Kasım 2006, (Tam Metin Bildiri)

252. Refrakter ve Relaps Akut Myeloblastik Lösemide EMA Kurtarma Rejimi Sonuçlarımız

TOPÇUOĞLU P., CİVRİZ BOZDAĞ S., YÜKSEL M., ARSLAN Ö., GÜRMAN G., DEMİRER T., et al.
XXXII. Ulusal Hematoloji Kongresi, Türkiye, 8 - 10 Kasım 2006

253. Allogeneic hematopoietic cell transplantation after reduced intense conditioning as adoptive cell therapy in resistant metastatic colorectal carcinoma. The European experience.

Aglietta M., Barkholt L., Caravelli D., Minotto C., Capaldi A., Omazig B., et al.
42nd Annual Meeting of the American-Society-of-Clinical-Oncology, Georgia, Amerika Birleşik Devletleri, 2 - 06 Haziran 2006, cilt.24, (Özet Bildiri)

254. Allogeneic hematopoietic cell transplantation (Allo HCT) for metastatic breast cancer (MBC)

Uenos N., Rizzo J., Cheng Y., Childs R., Stiff P., Demirer T., et al.
32nd Annual Meeting of the American-Society-for-Blood-and-Marrow-Transplantation, Hawaii, Amerika Birleşik Devletleri, 16 - 20 Şubat 2006, cilt.12, ss.32, (Özet Bildiri)

255. European experience of allogeneic hematopoietic stem cell transplantation for metastatic renal carcinoma: On behalf of the French ITAC group and the EBMT solid tumour working party

Barkholt L., Bregni M., Remberger M., Blaise D., Peccatori J., Massenkeil G., et al.
32nd Annual Meeting of the American-Society-for-Blood-and-Marrow-Transplantation, Hawaii, Amerika Birleşik Devletleri, 16 - 20 Şubat 2006, cilt.12, ss.21, (Özet Bildiri)

256. Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing

Peccatori J., Barkholt L., Demirer T., Sormani M. P., Bruzzi P., Ciceri F., et al.
8th National Congress of Medical Oncology, Milan, İtalya, 18 - 21 Kasım 2006, cilt.17, (Özet Bildiri)

257. Allogeneic haematopoietic cell transplantation in acute myeloblastic laeukemia: Ibni Sina experience (1989-2004)

Ilhan O., Topcuoglu P., Arat M., Soydan E., TOPRAK S. K., YÜKSEL M., et al.
31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group, Prague, Çek Cumhuriyeti, 20 - 23 Mart 2005, cilt.35, (Özet Bildiri)

258. High-dose BCNU followed by autologous haematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: an EBMT retrospective analysis of 218 patients

Bay J., Durando X., Linassier C., Biron P., Kwiatkowski F., Verrelle P., et al.
31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group, Prague, Çek Cumhuriyeti, 20 - 23 Mart 2005, cilt.35, (Özet Bildiri)

259. Allogeneic stem cell transplantation in advanced soft tissue sarcomas: a retrospective analysis on the EBMT Solid Tumours Working Party (STWP)

Grosso F., Corradini P., Carrabba M., Castagna L., Pedrazzoli P., Gobel U., et al.
31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group, Prague, Çek Cumhuriyeti, 20 - 23 Mart 2005, cilt.35, (Özet Bildiri) Sürdürülebilir Kalkınma

260. The comparison of myeloablative versus reduced intensity conditioning regimen in ABO mismatched allogeneic hematopoietic cell transplantation.

Topcuoglu P., Arat M., Bolukbasi T., Soydan E., Ozer Y., Ozcan M., et al.
46th Annual Meeting of the American-Society-of-Hematology, California, Amerika Birleşik Devletleri, 4 - 07 Aralık 2004, cilt.104, (Özet Bildiri)

261. Allogeneic hemapoietic progenitor cell collection using four different cell separators: A retrospective comparative analysis.

Arat M., Arslan O., Soydan E., Ayyildiz E., Dalva K., Tol M., et al.
46th Annual Meeting of the American-Society-of-Hematology, California, Amerika Birleşik Devletleri, 4 - 07 Aralık 2004, cilt.104, (Özet Bildiri)

262. Prognostic factors for survival in renal cell cancer patients undergoing allogeneic stem cell transplantation: A report from the EBMT Solid Turnouts Working Party

Bregni M., Peccatori J., Barkholt L., Ringden O., Pedrazzoli P., Martino R., et al.
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri) Sürdürülebilir Kalkınma

263. Graft-versus-tumour effect following reduced-intensity allogeneic stem cell transplantation in renal cell cancer

Barkholt L., Bregni M., Peccatori J., Pedrazzoli P., Remberger M., Carminati O., et al.
30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, İspanya, 28 - 31 Mart 2004, cilt.33, (Özet Bildiri)

264. Early high-dose chemotherapy for adult patients with extragonadal non-seminomatous germ cell tumours of the mediastinum and retroperitoneum

Rosti G., Papiani G., Wandt H., Leyvraz S., Demirer T., De Giorgi U.
30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, İspanya, 28 - 31 Mart 2004, cilt.33, (Özet Bildiri)

265. Long-term follow-up after high-dose chemotherapy for paediatric patients with extragonadal germ cell tumour

De Giorgi U., Rosti G., Slavin S., Yaniv I., Harousseau J., Tobler A., et al.
30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, İspanya, 28 - 31 Mart 2004, cilt.33, (Özet Bildiri)

266. High-dose thiotepa, melphalan and carboplatin followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - a retrospective evaluation

Demirer T., Soydan E., Fen T., Ilhan O., Ayli M., Arat M., et al.
30th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/20th Meeting of the EBMT-Nurses-Group/3rd Meeting of the EBMT-Data-Management-Group, Barcelona, İspanya, 28 - 31 Mart 2004, cilt.33, (Özet Bildiri)

267. Graft-versus-tumor effect following reduced-intensity allogeneic stem cell transplantation in renal cell cancer. On behalf of the EBMT solid tumours working party.

Bregni M., Barkholt L., Peccatori J., Pedrazzoli P., Remberger M., Carminati O., et al.
45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 Aralık 2003, cilt.102, (Özet Bildiri) Sürdürülebilir Kalkınma

268. Comparison of three conditioning regimens used in high-dose therapy of malign lymphomas: CBV-ICE-CTM

Soydan E., Arat M., Topcuoglu P., Demirer T., Arslan O., Ozcan M., et al.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Türkiye, 23 - 26 Mart 2003, cilt.31, (Özet Bildiri)

269. Secondary acute leukemia following mitoxantrone based high-dose chemotherapy for primary breast cancer

Kröger N., Damon L., Zander A., Wandt H., Derigs G., Ferrante P., et al.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Türkiye, 23 - 26 Mart 2003, cilt.31, (Özet Bildiri)

270. The EBMT Solid Tumors Working Party (STWP) registry: 2002 report

Demirer T., Kulekci A.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Türkiye, 23 - 26 Mart 2003, cilt.31, (Özet Bildiri)

271. Allogeneic stem cell transplantation in ovarian cancer: the EBMT experience

Bregni M., Peccatori J., Bernardi M., Pedrazzoli P., Siena S., Aglietta M., et al.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Türkiye, 23 - 26 Mart 2003, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

272. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation

Demirer T., Ayli M., İLHAN ., Koc H., Dagli M., Arat M., et al.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Türkiye, 23 - 26 Mart 2003, cilt.31, (Özet Bildiri)

273. High-dose chemotherapy in extragonadal germ cell tumor: first results of the EBMT Registry

Rosti G., De Giorgi U., Papiani G., Wandt H., Siegert W., Kozak T., et al.
29th Annual Meeting of the European Group for Blood and Marrow Transplantation/19th Meeting of the EBMT Nurses Group/2nd Meeting of the EBMT Data Management Group, İstanbul, Türkiye, 23 - 26 Mart 2003, cilt.31, (Özet Bildiri)
Kitaplar 3

1. Future Perspectives for Haploidentical SCT

ŞAHİN U., DEMİRER T.
Stem Cell Biology and Regenerative Medicine, Springer Nature, ss.189-199, 2017

2. Future Perspectives for Haploidentical Stem Cell Transplantation

ŞAHİN U., DEMİRER T.
Haploidentical Stem Cell Transplantation: An Emerging Treatment Modality, TANER DEMİRER, Editör, Humana Press, CHAM, ss.189-198, 2017

3. Toxicity of Conditioning Regimens in Haploidentical SCT

YÜKSEL M., DEMİRER T.
Stem Cell Biology and Regenerative Medicine, Springer Nature, ss.43-56, 2017
Metrikler

Yayın

500

Yayın (WoS)

305

Yayın (Scopus)

201

Atıf (WoS)

5668

H-İndeks (WoS)

42

Atıf (Scopus)

5711

H-İndeks (Scopus)

42

Atıf (Scholar)

133

H-İndeks (Scholar)

7

Tez Danışmanlığı

1

Açık Erişim

45
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER
SDG 5: AMAÇ 5: CİNSİYET EŞİTLİĞİ
SDG 16: AMAÇ 16: BARIŞ VE ADALET